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A REINFORCEMENT LEARNING APPROACH 
TO OBTAIN INTERVENTION STRATEGIES IN MEDICINE 
Radhika Poolla 
ABSTRACT 
 
 
Medical decision problems are extremely complex owing to their dynamic nature, 
large number of variable factors, and the associated uncertainty. Decision support 
technology entered the medical field long after other areas such as the airline industry and 
the manufacturing industry. Yet, it is rapidly becoming an indispensable tool in medical 
decision making problems including the class of sequential decision problems. In these 
problems, physicians decide on a treatment plan that optimizes a benefit measure such as 
the treatment cost, and the quality of life of the patient. The last decade saw the 
emergence of many decision support applications in medicine. However, the existing 
models have limited applications to decision problems with very few states and actions. 
An urgent need is being felt by the medical research community to expand the 
applications to more complex dynamic problems with large state and action spaces. This 
thesis proposes a methodology which models the class of sequential medical decision 
problems as a Markov decision process, and solves the model using a simulation based 
reinforcement learning (RL) algorithm. Such a methodology is capable of obtaining near 
 vi
optimal treatment strategies for problems with large state and action spaces. This 
methodology overcomes, to a large extent, the computational complexity of the value-
iteration and policy-iteration algorithms of dynamic programming. An average reward 
reinforcement-learning algorithm is developed. The algorithm is applied on a sample 
problem of treating hereditary spherocytosis. The application demonstrates the ability of 
the proposed methodology to obtain effective treatment strategies for sequential medical 
decision problems.
 vii
CHAPTER 1 
INTRODUCTION 
 
 
Ability to reason differentiates humans from other species. Reasoning leads 
humans to perceive, understand, analyze, and act. Humans act by making decisions and 
this process happens almost every minute of our lives. In situations involving many 
variables and possible decisions, decision support systems provide useful tools. A 
decision support system translates the real life scenario into a mathematical model for 
analysis. A set of decisions usually evolves from this process and, generally, the decision 
that best satisfies the objective of the analysis is carried out.  
Decision support systems have been gaining usage in many application areas 
including, pharmacy, manufacturing, finance, armed forces, aviation industry, and health 
sciences. Because of the complexity of decision making, health sciences have been a new 
and fast growing field of application. Factors such as multiple variables, uncertainty of 
action outcomes, difficulty of incorporating input obtained from domain experts into the 
model building process, and the time varying nature of the problems pose a tough 
challenge to the decision support experts as they try to fit such complexities into 
mathematical frameworks, which are more parameterized. Techniques from the fields of  
Statistics and Probability are proving useful to model some of these complex situations 
efficiently and to arrive at the best possible decisions.
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1.1 Sequential decision problems 
Diagnostic testing, therapy planning, and other clinical scenario, comprise of the 
physical condition of the patients, the interventions, which are diagnostic tests and 
treatments, or a combination of both. These, medical scenarios, usually, comprise of 
problems which, involve a trade-off between certain events affecting the health of a 
patient and the risk of a certain intervention to avert the events. Both the associated risk 
and the health of a patient may vary over time, which makes the situation uncertain for 
the physician to predict accurately. The objective of such medical problems is to find a 
suitable therapeutic plan for the patient under observation, which would maximize the 
quality of life of the patient in a cost effective manner. 
A typical sequential decision problem arises when a patient approaches the 
physician, and the physician, depending upon the patient’s health situation, decides to 
either  intervene immediately or to wait and see for some time, with the objective of 
maximizing the quality of life for the patient. If the physician believes that the patient’s 
life is at risk or the patient’s health would be severely affected if he or she were left in the 
same condition, the physician might opt for an intervention. But if the physician is unsure 
about the need for an intervention and prefers to keep the patient under observation, then, 
a preferred strategy could be ‘wait and see’. Questions listed below could arise in the case 
of  adopting a ‘wait and see’ strategy. 
T How long should the physician observe the patient before the decision is 
revisited? 
T Should the patient’s condition be continuously monitored or in discrete intervals? 
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In the case of interventions, the side effects from the interventions can lead the 
patient into a different situation, which the physician may not be able to predict with 
certainty. Moreover, there could be many modes of interventions, such as medicinal and 
surgical. Selecting a mode that would provide the best possible treatment to the patient at 
that particular time and situation could be a difficult task. 
 Age of the patient and sex might be two other factors, which the physician has to 
keep in mind, while taking such a decision. Ethnicity of the patient may not be taken into 
consideration. In addition to all these, another problem feature, which confronts the 
physician is the dynamicity of the problem. A patient’s physical condition may vary with 
time during the course of the treatment. For such problems, decision support systems 
could help the physicians in taking quick and efficient decisions to maximize the quality 
adjusted life years (QALY) of a patient in the long run. A QALY is a measure of the 
quality life that the patient enjoys in a year. 
1.2 Some medical decision problems  
1.2.1 Spontaneous pnemothorax 
The problem of finding an optimal strategy for primary spontaneous 
pneumothorax, (Lin et al. (2002) [1]), in young men is a typical decision problem, that 
falls under the category of intervention problems. This has been modeled using a Markov 
decision process with a state space of five and an action space of six. The objective was 
to maximize the quality adjusted life years of a patient.  
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1.2.2 Chronic angina (chest pain) 
In the case of chronic stable angina, the decision problem involved is to determine 
the treatment and the time of treatment such that the quality adjusted life expectancy of a 
patient is optimized. The actions usually available in this scenario are medical treatments, 
percutaneous transluminal angioplasty, and coronary artery bypass graft. While the 
selected treatment progresses, complications occur requiring other decisions. Hence, the 
sequence of decisions taken depending on the situation of a patient is very crucial to 
maximize the objective function, the quality-adjusted life expectancy. This problem was 
modeled in the literature as a Markov decision process (MDP) having five state variables 
and three actions (Leong T.Y. (1994) [2]). 
1.2.3 Chronic cough 
This problem, (Lin et al. (2002) [3]), involves, finding the most cost-effective 
management strategy, out of the available strategies, to treat chronic unexplained cough. 
The model used is a MDP with six treatment strategies. 
1.2.4 Severe head injury management 
In the case of severe head injury, (Harmanec et al. (1999) [4]), the management 
becomes extremely difficult owing to the time-critical nature of the injury, the 
complexities involved in the scenario, and the uncertainty of the intervention procedures.  
The decision model presented in [4] considers nine treatment options and the influence 
diagram approach. 
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1.2.5 Colorectal cancer follow up 
Patients with colorectal cancer undergo curative surgery. The follow up period 
after the surgery is very important as there could be either recurrence of the cancer or 
development of tumor or both. If the recurrence or tumor is detected at an early stage 
during the follow-up, the chance of successful curative treatment can be improved. For 
the detection, the doctor needs to perform a series of diagnostic tests. 
The decision problem (Zheng et al. (1998) [5]) here, is to find out the optimal 
course of tests depending on the stage of health of the patient during the follow-up, which 
would ultimately lead to the most cost-effective treatment sequence. This problem was 
modeled with seven actions and five state variables as a semi-markov decision process 
(SMDP). This model has been solved using the value-iteration technique by using 
DynaMol- dynamic decision modeling language, developed by T.Y. Leong (1998) [32], 
which takes inputs as the conditional probabilities and the influence view of the problem. 
1.2.6 Chronic leukemia 
Patients who are born with errors in their immune system and patients who have 
diseases like severe aplastic anaemia, and chronic leukemia are treated by allogenic bone 
marrow transplantation. But during this transplantation, the patient’s cells could develop 
a negative reaction to the donor’s cells. This complication is called graft versus host 
disease (GVHD), which occurs frequently and is deadly. 
In the case of leukemia patients, mild GVHD helps in preventing disease relapse. 
Therefore, though severe GVHD is dangerous, mild form of GVHD is advantageous to 
the transplantation. Leukemia patients are treated with immuno suppressive drugs in 
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order to prevent or control GVHD. The dosage of these drugs should be optimal such that 
they clear the complication caused by GVHD and at the same time control the GVHD to 
benefit the transplantation. 
Thus, the decision problem (Paolo Magni et al. (1997) [6]) is to specify both type 
and dosage of the drugs in order to either avoid or to induce GVHD according to the 
patient’s specific condition and drug’s toxicity. This problem has been modeled as a 
MDP with four actions and five state variables forming the state space. Influence views 
were used to model the problem. The details were supplied to a software called DT-
Planner, which models the problem as an MDP and solves for an optimal policy using 
well known algorithms, such as value iteration and policy iteration. The policy that 
maximizes the survival time while minimizing the risk of drug toxicity was adopted.  
1.3 Current approaches 
The main approaches that have been used in studying the problems discussed 
above are given below. 
1.3.1 Static models 
In this approach, the decision problems are solved at several time instants and the 
set of solutions are then presented as a dynamic strategy. Such a model presents a crude 
approximation and leads to a sub-optimal solution. 
1.3.2 MDP & SMDP  
A Markov Decision Process (MDP) model consists of a set of possible states S, a 
set of possible actions A, a reward function R(s, a). The actions can be of two types, 
namely, deterministic and stochastic. Deterministic actions are those, where, for each 
 6
state and action, a particular new state is defined. Where as, for a stochastic action, for 
each state and action, a probability distribution has to be specified over the next states. 
The solution expected to a problem, by modeling as a Markov decision process is 
an optimal policy. Optimal policy tells, which action to be followed in a particular state, 
so that, the total expected reward could be maximized. Semi-Markov Decision Process 
(SMDP) goes a step further in taking the time spent in a particular state also, into account 
for analysis. Medical problems can fit into these mathematical models, though with some 
assumptions and constraints. 
1.3.3 Graphical formalisms 
Many decision-making frameworks make use of graphical formalisms to easily 
accommodate the complexities of the problems. These formalisms by themselves cannot 
give a solution to a problem. They have an underlying mathematical framework, which 
models the actual problem. These formalisms, as given below, are useful for easy 
understanding of the problem. Below given are some of the formalisms in use. 
1.3.3.1 Dynamic influence diagrams 
  Dynaimic influence diagrams are direct acyclic graphs. T.Y. Leong [32] depicted 
a influence duagram, which is as shown in  Figure 1. The squares denote the decision 
nodes, the circles denote the chance nodes and the rhombus’ denote the value nodes. 
Inside, each node, there is a number, which indicates the decision stage in which the 
decision/event/value is considered. Arcs leading to chance and value nodes in the figure 
denote the probabilistic dependencies and arcs leading to the decision nodes indicate the 
informational dependencies. The possible value of the outcome of a chance node or a  
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Figure 1. Dynamic influence diagram 
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value node is embedded in each of them. One diagram is enough to model a situation 
with any number of actions. 
1.3.3.2 Markov cycle trees 
In a Markov cycle tree, the branches of the tree come out of the root node, which 
is called as the Markov node. For a given action, the leaf nodes represent the states at the 
beginning and at the end of a decision stage. 
The arcs indicate the possible outcomes and also the conditional dependencies 
among the nodes. A utility function is always defined for each of the states in the 
diagram. The number of Markov cycle trees for a given problem will be equal to the 
number of actions available. The uncertainty in the problem and the variation with time 
would lead to extreme complexity of the Markov cycle trees. T.Y. Leong depicted the 
Markov cycle tree in [32], as shown in Figure 2. 
0.26
0.94
0.02
0.72
Sick
Well
Markov node
Chance node
Leaf node
Dead
Dead
Dead
0.06
1.00
Probabilistic 
dependence 
Well 
Sick 
 
Dead 
 
Well 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Markov cycle tree 
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1.3.3.3 State transition diagrams 
As shown in Figure 3, the nodes denote the states and the arcs denote the possible 
transitions given an action. The transition probabilities are denoted above the arcs. A 
utility function is defined for each state in the diagram.  
 
1.00
0.50
0.25
0.25
0.25
0.25
0.50
dead
sickwell
 
 
 
 
 
 
 
Figure 3. State transition diagram 
1.3.3.4 Influence views 
An influence view is a diagram wherein the events taking place in a single 
transition are modeled. For each action defined in the problem, an influence view can be 
drawn. This is very similar to the transition diagram, except that, in this, the events are 
modeled as nodes whereas in a transition diagram, the states are modeled as nodes. Also, 
in an influence view, a conditional distribution table is associated with each node, which 
is comparable to the transition probabilities associated with the arcs in a transition 
diagram, only difference being that the transition probabilities are far more difficult to 
obtain than the conditional probabilities. Paolo Magni et al. [8] depict an influence view 
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as shown in Figure 4. The information obtained from an influence view can always be 
obtained from a properly drawn transition view, except for the difficulty of obtaining the 
exact transition probabilities from the existing medical databases concerning the problem. 
Artificial Intelligence researchers have been working on the dynamic decision 
problems with other methodologies, like the ones mentioned below. Sometimes, 
statistical techniques and AI methods are being combined and used for modeling. 
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Age NatDeath
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Figure 4. Influence view 
1.3.3.5 Decision trees 
Decision trees have always been popular in sequential decision-making. The other 
advantages of a decision tree are that, it can easily be translated into convenient if-then 
rules. Constraints also can be easily imposed. However, the decision tree needs to be 
 11
learned through heuristic procedures, as the problem of finding the best tree is an NP-
hard problem. The major disadvantage of decision trees is that they are not suitable for 
time varying problems. 
1.3.4 Neural networks 
A neural network consists of a set of nodes called the input nodes, output nodes 
and intermediate nodes. Input nodes receive the input signals. Output nodes give the 
output signals and a large number of intermediate layers contain the intermediate nodes. 
Such networks can be built using special hardware, but most of them are just software 
programs that can operate on normal computers. 
There are two stages involved in the neural network learning, 
T Encoding stage: Neural network is trained to perform a certain task, 
T Decoding stage: Neural network is used to classify examples, make predictions  
                           or execute whatever learning task is involved.  
Different forms of neural networks are perceptrons, back propagation networks, and 
kohonen self-organizing map. 
1.3.5 Belief networks 
Belief networks help in modeling phenomenon, which have an uncertainty 
element. They deal with reasoning under uncertainty. Bayesian belief networks are 
directed acyclic graphs with a set of nodes interconnected with arcs. Each node represents 
an uncertain quantity or a random variable. The arcs link the variables, which have direct 
influence over each other. The influences are shown over the arc with the help of 
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conditional probabilities. Belief networks have applications in medical diagnostic 
systems, weapons scheduling, and computer processor fault diagnosis, to name a few. 
1.3.6 Genetic algorithms 
These are basically adaptive, heuristic search algorithms based on the 
evolutionary ideas of Charles Darwin. Their intelligent exploitation of a random search 
within a defined search space to solve a problem makes them outperform other traditional 
methods. Being good at solving problems, involving, finding optimal parameters, they 
are especially useful in optimization. 
Genetic algorithms can be applied to problems where the search space is large and 
complex, domain knowledge is scarce and where mathematical analysis is not available. 
Machine and robot learning, economic models, ecological models and automated 
programming are some of the areas, for which, genetic algorithms have been applied. 
1.3.7 Rough set theory 
Rough set theory mainly deals with classification of data tables. It is one of the 
techniques available to search large databases for meaningful decision rules and to 
acquire new knowledge. It has found applications in medical data analysis, image 
processing and voice recognition. 
1.4 Brief description of the problem 
One such decisio problem is the Hereditary Spherocytosis problem considered in 
this thesis. In this disease the patient suffers from being anemic because of the red blood 
cell destruction. If the patient is not cured, then there is an increasing risk of gall stone 
formation, in addition to the red-blood cell destruction. On the other hand, if the 
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physician intervenes, in an attempt to cure the patient, a septic condition called sepsis can 
develop. 
Five possible interventions are available for the physician to choose from, 
depending upon the patient’s condition. But, the problem lies in taking these decisions at  
appropriate patient conditions so as to maximize the quality adjusted life days of the 
patient. The patient’s condition changes continuously adding a dynamic dimension to the 
problem. The changing condition of the patient, the side effects arising from the medical  
interventions, and the amount of patient discomfort are some of the issues that a 
physician has to continuously monitor and keep in mind while choosing the intervention 
strategy. 
1.5 Existing solution methodology 
The problem of selecting an intervention strategy for Hereditory Spherocytosis 
has been modeled in the literature using a static modeling formalism by Marchetti et al. 
(1998) [7]. Later, it has also been modeled by Paolo Magni et al. (2000) [8] as a Markov 
decision process to accomodate the dynamic perspective. The Markov cycle has been 
fixed at one year. Influence views were used to describe the effects of the four possible 
action choices. State of gallstones and state of spleen characterized a patient’s health 
condition or states of the MDP. Quality adjusted life years is considered as the utility 
function. The decision problem is to find the best action in every state of the patient to 
maximize the quality adjusted life expectancy of a patient. Obtaining transition 
probabilities for the states for every action and then solving for the optimal policy using 
the existing value iteration algorithm constitute the solution procedure of the Markov 
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decision process. The transition probabilities are usually deduced from the conditional 
probabilities obtained from the medical databases. 
1.6 Need for better methods 
There are two existing dynamic programming algorithms to solve for the optimal 
policy of a MDP, namey, value and policy iteration. The computational complexity of the 
value-iteration algorithm per iteration is quadratic in the number of states and linear in 
the number of actions. In other words, each iteration can be performed in O(|A| |S|2) 
steps. On the other hand, policy iteration converges faster than value iteration, but takes 
O(|A| |S|2 + |S|3) steps per iteration. Thus, the computational complexity increases 
enormously with even a slightest increase in the action and state spaces. 
Most of the medical problems, when modeled as a MDP or as a SMDP, because 
of the very nature of the problems, could end up with a large state space and a number of 
possible actions. For such problems, it becomes difficult to arrive at the optimal policy 
because of the issue of the computational complexity. The transition probability matrices 
become very large requiring lot of memory to store all the states. Also, much 
computational time is required for the value iteration or the policy iteration algorithms to 
converge, which is not feasible. Therefore, computationally efficient approaches are 
needed to obtain the optimal policy.  
In the models studied in the literature, the state space of the Hereditory 
Spherocytosis problem has been reduced considerably comprising of only the state of 
gallstones and the state of spleen. Age and sex have not been considered. Moreover, time 
after splenectomy, sepsis formation, and other complexities have all been ignored in 
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establishing the state space. Thus, even though the problem has been studied as a MDP, 
significant elements of the problem have been left out to achieve simplicity giving only a 
few states to deal with. As a result, the previous researchers were able to immediately 
implement the value iteration or the policy iteration techniques and arrive at optimal 
policies. But in reality, if all the relevant issues of the medical problem were to be taken 
into consideration, the state space would grow quickly, requiring very high computation 
time. 
1.7 Approach considered 
1.7.1 Reinforcement learning (RL) 
Instead of directly applying value-iteration or the policy-iteration algorithms, an 
indirect way to arrive at the optimal or, near optimal policy is by estimating a value 
function using the method of reinforcement learning on a simulation model of the 
problem. This is a viable alternative for obtaining near optimal policies for large scale 
MDPs with considerably less computational effort than what is required for DP 
algorithms. RL has two distinct advantages over DP. First, it avoids the need for 
computing the transition probability and the reward matrices. The reason being that it 
uses discrete event simulation as its modeling tool, which requires only the probability 
distributions of the process random variables (and not the one step transition 
probabilities). Secondly, RL methods can handle problems with very large state spaces 
since its computational burden is related only to the value function estimation, for which 
it can effectively use various function approximation methods such as, regression, and 
neural networks. Therefore, when the model of an environment can be simulated and 
 16
inputs such as rewards can be given, reinforcement-learning algorithm can be applied to 
get the optimal policy.  
The hereditary spherocytosis problem that is considered in this thesis, has 1911 
states and five actions. Therefore, the transition probability matrix is of the size (1911 ×  
1911). The idea is to simulate the model of the situation and embed it into the 
reinforcement learning technique. Thus, an optimal policy, which dictates, according to 
the patient’s condition, what surgery to be performed and when it should be performed, 
can be obtained. Also, this process would give the physician an idea about the QALY 
(quality adjusted life years), the patient would enjoy, given, the optimal policy that is 
followed. Such a decision support system hopes to aid the physicians in the decision-
making process. 
1.8 Summary of remaining chapters 
The rest of the thesis is organized as follows. Chapter 2 is the literature review, 
which discusses the existing literature on the medical decision problems, and the 
approaches, which the researchers took to model them. Chapter 3 discusses in detail 
about the problem being addressed and reveals the research objectives. Chapter 4 goes at 
length into the proposed methodology, assumptions involved and describes the proposed 
algorithm. It also discusses the future agenda. References and Appendices have been 
provided at the end. 
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CHAPTER 2 
LITERATURE REVIEW 
 
 
This chapter summarizes the existing research on the topic, “Medical-decision 
making for the class of intervention problems.” It describes the work of selected 
researchers and the solution methodologies adopted by them. Thus, the chapter gives an 
idea, of the gradual progress in modeling and solving the decision problems from the 
domain of medicine. 
Research on medical decision-making is about a decade and a half old and a 
fertile area for research. In this section, the different kinds of decision problems and 
techniques, which evolved to solve them, have been described. The problems related to 
medical interventions and clinical prognoses were being studied from long. But, 
formulating these problems as models, using statistical methods and artificial intelligence 
techniques began in the late 80’s. 
2.1 Decision trees 
Early papers attempted to model the medical decision problems, in clinical 
settings, using decision trees. The reader is referred to Hollenberg (1984) [9] and Lau et 
al. (1983) [10] for further discussion on decision trees and recursive decision trees, 
respectively. But soon, it was realized that, this method involved assumptions, which 
were far from reality.  
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Sonnenberg and Robert Beck (1993) [11] explained, why decision trees and 
recursive decision trees, are not suitable to model decision problems in medicine. The 
following explanation is adopted from their paper. Decision problems involve an ongoing 
risk over time, because of which, there are two important consequences. One is the 
uncertainty of the times at which the events occur. Second, is the repetition of a given 
event. The decision tree modeling does not tell, as to when the events occur in time. Also, 
there is a problem of assigning utilities to the terminal nodes, because they do not 
represent an end but represent the prognosis of the patient for such an outcome, as is the 
node. The second consequence, that is the repetition of a given event, can be modeled by 
recursive decision trees. The problem in such modeling is that, the branches of the tree 
might increase exponentially with each repetition, making it impossible to track. Hence, 
Sonnenberg and Beck describe the markov model approach in this paper, which they felt 
was appropriate to model the decision problems. With the description of the use of 
Markov models for prognosis in medical applications by Beck and Pauker (1983) [12], 
Markov models have been applied and analyzed on many decision-making problems in 
medicine. 
2.2 Markov cycle trees 
In 1984, Hollenberg [9] introduced the Markov cycle trees, which have been used 
by some researchers in modeling. In 1993, Sonnenberg et al. [11], explained that Markov 
models are especially useful for decision problems, which involve risk, that is continuous 
over time. Methods were also described to evaluate markov models. It was concluded 
that, the ability of the markov models, to represent repetitive events and the time 
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dependence of both probabilities and utilities, allows for more accurate representation of 
the clinical settings. Three important ways of modeling in the Markovian manner were 
discussed. Namely, the matrix solution, the cohort simulation and the markov cycle trees. 
Also, the use of markov cycle trees was demonstrated by implementing the methodology 
to a case history of a 42-year old man, who had had a kidney transplant. While the patient 
was receiving normal immuno-suppressive drugs, a decision problem arouse. The 
continuation of drugs might give rise to a complication, but if the drugs were stopped, the 
kidney might be rejected. Therefore, the doctor had to decide on a treatment strategy, that 
maximizes the quality of life expectancy of the patient. The author by comparing, 
concludes that, Markov cycle trees are a suitable representation than decision trees. They 
also stated that, Markov cycle tree is a formalism that combines the modeling power of 
the Markov process with the clarity and convenience of a decision tree representation. 
The above-described medical problem was modeled by Kassier et al. (1988) [13] as a 
decision tree, prior to Sonnenberg and Beck. 
2.3 Stochastic trees 
At around the same time, Hazen (1992) [14] introduced, how medical decision 
problems based on age-dependant mortality rates and declining incidence rates may be 
modeled using stochastic trees. In this paper, it was shown that stochastic trees possess 
important advantages over the markov cycle trees for medical decision modeling. The 
stochastic tree is a continuous time version of a Markov cycle tree, useful for 
constructing and solving medical decision problems, in which risks of mortality and  
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morbidity may extend over time. Hazen (1993) [15] introduced the notion of factoring a 
large stochastic tree into simpler components, each of which may be easily displayed. 
This paper extends the idea of his previous paper, where stochastic trees were introduced. 
2.4 Markov models 
In the five part series of “Primer on medical decision making”, authors, Krahn 
MD, Naglie G, Naimark D, Redelmeier DA, Detsky AS, (1997) [16,17,18,19,20] laid 
considerable emphasis on the Markovian way of modeling. Interested readers can refer to 
this excellent review, on decision problems and factors to be considered, while modeling 
them. Issues like, choosing an appropriate problem, determining the trade-off between 
accuracy and simplicity and deciding on a time frame have been discussed in Part 1 [16] 
of the series. Part 2 [17] of the series discusses, the construction of a decision theoretic 
approach for the giant cell arteritis (GCA) case. Part 3 [18] discusses the role of decision 
trees in modeling. Part 4  [19] describes how to derive probabilities and also describes 
bug proofing of decision trees. Part 5 [20] describes the same case as in Part 1, which has 
been modeled using Markov analysis. Though the authors suggest the Markovian way, 
they also leave a word of caution, that, model builders be aware of the pitfalls in this 
approach and suggest that the analyst must weigh the simplicity and clarity of a 
conventional tree against the fidelity of a Markov analysis. Part 5 concludes with the 
inference, that, there doesn’t seem to be any significant qualitative difference between the 
markov approach and the simple tree approach.  
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2.5 Dynamic decision models 
As different researchers tried to model the problems in different promising ways, 
Leong (1991) [21] attempted to model the medical decision problems, by focusing on the 
ontological features of the problem, like classes of actions, classes of events, classes of 
outcomes, probabilistic dependencies and temporal precedence. This attempt was made 
keeping in view, automating the construction of decision models in medicine. The 
proposed system, described in this paper consists of a planner, which constructs a 
decision model by accessing the medical knowledge database, and solves the model. The 
solution is given to the user. The user helps the planner in doing its job, by giving certain 
inputs. The results of this paper show that, to support dynamic decision modeling, the 
structure of the knowledge base, must reflect the nature of both the decision problem and 
the domain knowledge. Qualitative probabilistic network was used in modeling. 
Leong (1992) [22] tried to represent knowledge, which is based on the context of 
the problem, as a network. She believed that, complexity in the medical problem’s 
knowledge occurs due to the variations in the contexts of the underlying phenomenon. In 
that way, a framework has been proposed, which attempts to model the uncertain 
knowledge in network formalism. In this paper, she explains, how to represent uncertain 
situations in a network form, various components of the network and its applications. She 
worked with the different structural relations, uncertain or behavioral relations, context 
dependant notions and different relevant phenomenon of the problem, to model it as a 
decision problem, though the implementation was left to be done. 
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Leong (1993) [23] identified that Semi-markov decision process (SMDP) can be 
taken as the common theoretical basis for solving the decision problems. Until this point 
of time, simple Markov decision process (MDP) has been in use. In this paper, it was 
explained that the complexity involved in the decision modeling could be avoided by 
dealing directly with its underlying mathematical framework like an SMDP, which would 
be more near to the practical situation. In an SMDP, the duration for which a patient is in 
a particular state, which is yet another dimension of uncertainty, can also be taken into 
consideration. It was also pointed out that, though, there are different formalisms suitable 
for different kinds of problems, it should be realized that the underlying mathematical 
framework for solving any of these problems is the same. It is either an MDP or an 
SMDP. In this paper, the example of a typical medical decision problem, “The 
management of chronic ischemic heart disease” was considered and modeled using three 
different formalisms, namely, dynamic influence diagrams, stochastic trees and Markov 
cycle trees. The pros and cons of the formalisms, were discussed and the paper concludes 
with the notion, that, difficulty in modeling medical problems is not with the formalism, 
but, is with the computational complexity of the value-iteration or the policy-iteration 
technique of the underlying dynamic programming formulation, which cannot be 
avoided. This paper can be considered as an important milestone in the research related to 
this area. 
In an attempt to provide a general framework for modeling and solving decision 
problems, Leong (1994) [24], came up with a framework called, “Dynamic decision 
modeling language” (DynaMol). The idea behind this, as she explains, is to have a 
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general framework, which can handle any type of graphical formalism, as long as the 
underlying methodology is an SMDP. According to the paper, the framework provides a 
unifying task definition and a common vocabulary for the relevant decision problems and 
also balances the trade-off between model transparency and solution efficiency in the 
current frameworks. In this paper, Leong essentially describes the DynaMol design, the 
dynamic decision grammar, which, comprises of terms related to modeling, the graphical 
representation convention and the solution methods. The paper also summarizes the 
assumptions involved in the design of DynaMol such as,  
T Same states should be valid through out the decision horizon, 
T Same set of actions is applicable in each state, 
T Transition probabilities can vary with time, 
T Semi-Markov decision process has limited memory regarding the past events. But 
in some cases, the memory about previous states and actions could be important. 
Leong notes that DynaMol should be extended to take care of such things. 
Cao et al. (1996) [25] discusses, issues like the requirement for a multiple 
perspective dynamic decision modeling language, the design of DynaMol framework, the 
semantics and the grammar. Further literature on the same topic, can be obtained, in the 
technical report by Leong (1994) [26]. This contains all the work done by her, in the area 
of medical decision making until the year 1994.  
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Leong  (1996) [27] explained DynaMol in detail and implemented it on the 
“Atrial fibrillation” case. The problem was modeled using influence views and SMDP as 
the underlying framework. DynaMol models the problem, translates into the grammar of 
the underlying framework, solves and finally analyses it. 
Leong (1996) [28] illustrates, further improvements in the DynaMol design, 
which accommodates “translators”. Graphical representations often help the analyst in 
understanding and in easily accommodating all the complex factors of the medical 
problems. But there are various types of graphical formalisms, like the influence views, 
transition views, and markov cycle trees. Depending on the analyst, the problem can be 
represented using any of the above and can be fed to DynaMol. DynaMol, then, translates 
that particular graphical formalism, first to a transition view and then to the underlying 
mathematical framework. This translation convention has been elaborately discussed in 
this paper and the present DynaMol design was implemented and tested on the case study 
of the atrial fibrillation case. 
In 1998, Cungen Cao et al. [29] proposed a technique, through which diagnostic 
test strategies can be obtained. This technique is very different from the MDP modeling 
and uses the artificial intelligence techniques. It is similar to the decision tree technique 
and gives a diagnostic test strategy from medical data. The authors call this modeling, a 
‘strategy tree’. This tree can be induced from three types of information measures, 
namely, K-level information gain, K-level gain ratio and K-level cost effectiveness. The 
test, which provides the most information, has a larger information gain ratio and thus, 
selected. The induction of the strategy tree depends on the previous tests selected. The 
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cost of the test strategy is taken into consideration, to resolve in case of two tests of same 
information gain ratio. Cost, here, is the reward obtained. In the authors’ words, the 
building of the strategy tree is more or less similar to a decision tree building, except for 
the difference, that the tree is also built in a level-by-level manner, in addition to the 
divide-and-conquer manner. 
Sunderesh et al. (1999) [33] extended the DynaMol framework, by embedding 
abstraction mechanisms, which allows the end user to switch between representations of 
the medical problem. This is called abstract modeling, which gives guidance to the user, 
through the involved constraints in the problem. 
Harmanec et al. (1999) [34] attempted to model the problem of “Severe head 
injury management”, using a simple influence diagram. The decision problem involved 
was to prescribe an optimal treatment plan to a severe head injury patient in an ICU 
setting. This problem is different from other decision problems, considering its criticality 
and large number of complex factors and parameters varying in minutes. Two ways of 
parameter elicitation were proposed and the authors concluded that, more efficient 
strategies for obtaining the numerical parameters involved are needed, even though the 
problem produced reasonable recommendations.   
An excellent critical review paper, came into the research area of medical 
decision problems, when, Peter Lucas et al. (1999) [35] described, the various decision-
making methodologies, used in the field of statistics and probability and in artificial 
intelligence (AI). In this paper, restricted probability models, decision trees and Markov 
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processes have been grouped under the statistical methods. Neural networks and 
Bayesian belief nets were grouped under the AI techniques. 
Qi and Leong (2001) [36] set up a method, for automatically constructing 
influence views for the medical problems, directly from data. The conditional 
probabilities for the influence views can also be automatically generated, using Bayesian 
approach described by Cao et al. (1997) [37]. This methodology was accommodated in 
DynaMol.  
In the two papers, Lin et al. (2002) [38] [39] solved two problems, namely, 
“Spontaneous pneumothorax” problem and the “chronic cough” problem, using the 
SMDP modeling, which she proposed earlier and represented the problems in the 
influence view formalism. Also, in 2002, YP Xiang and KL Poh [40] published a paper, 
which models medical problems, which are time critical in nature. Usually, for decision 
analysis, it takes considerable time. But in critical medical problems, the decision has to 
be taken in a matter of minutes and that adds, the constraint of limited time, to the 
decision problem. To formulate such problems, Xiang and Poh, proposed, a time critical 
dynamic influence diagram (TDID), which can represent both space and time abstractions 
within the model. Further, they proposed four algorithms to solve the TDID’s. The 
authors follow a meta-reasoning approach to select the appropriate algorithm, from the 
four algorithms, in terms of computational complexity and decision quality. This 
methodology was implemented on a cardiac arrest problem and the results looked 
promising. 
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2.6 Obtaining the numbers 
In the 1990’s, while various methodologies were being proposed for modeling the 
medical decision problems, research for obtaining the required numerals (probabilities) 
used in the models as inputs, was also progressing. The extraction of transition 
probabilities and the action rewards, required in modeling, became an important topic of 
research. The transition probabilities needed for the MDP, has to be, either obtained from 
the domain experts or have to be extracted from the medical databases. 
Cao and Leong (1996) [25] attempted to automate the learning of transition 
probabilities and action rewards, required in the modeling of an MDP, from the medical 
databases. It was suggested in the paper, that static comparison is an efficient method to 
extract the transition probabilities, in which the transition cases have been divided into 
three semantic classes. Using this method, the paper claims, that the issues of incomplete 
and infrequent databases can be overcome to a considerable degree. 
Cao et al. (1997) [37] proposed a Bayesian method, for automated learning of 
conditional probabilities, from large medical databases. Obtaining probabilities from 
domain experts, also, has been analyzed. Several issues on pre-processing raw data, for 
applying to the decision problems were discussed. The learning from databases of 
probabilities is based on the DynaMol framework. The proposed methodology was 
implemented to the problem of colorectal cancer and results have been obtained. 
In 1998, Cungen Cao et al. [41] published his Bayesian approach, to automatic 
generation of conditional probabilities and its results. Lau and Leong (1999) [42], 
proposed a framework, which can obtain the probability distributions for the decision 
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problems from domain experts. These distributions are very important, as they represent, 
the uncertainties in the system. This framework involves the doctors in getting 
probabilities and also tries to minimize the bias in the probabilities given by them. 
Zhao (2000) [43] proposed, an automated data pre-processing framework, which 
uses database scripts, for processing databases before eliciting probabilities for dynamic 
decision models. Thus, the eliciting of the numbers is by itself, an interesting area of 
research in the domain of medical decision-making. 
2.7 Static modeling 
DT-Planner is a software package written in Ansi-C language. This is developed 
by Paolo Magni et al. (1997) [6] to design and solve dynamic decision problems. It 
makes use of influence views, to represent the problem. A user-friendly graphical user 
interface, allows the user to navigate through the built in menus, to draw the influence 
view of the problem and to input the conditional dependencies, involved, between the 
events of the problem. The software models the problems as an MDP and then calculates 
the transition probability matrix. DT-Planner solves the problem, using the value-iteration 
algorithm to find the optimal policy. Elimination algorithm, by Rina Dechter (1996) [44], 
is used to remove event variables from the influence view and to compute the equivalent 
MDP. The problem of “allogenic bone marrow transplantation” has been implemented, 
using this software and the optimal policy obtained was convincing. 
The problem of the “Heriditary Spherocytocis” (HS) disease has been lurking 
through the minds of researchers for quite some time. Patients with mild HS, have an 
increased risk of gall stone formation and complications. Various treatments are 
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available, out of which, Marchetti et al. (1998) [45] considered, three treatment strategies, 
namely, ‘splenectomy’, ‘cholycystectomy’ and ‘no surgery’, so that the problem can be 
simplified. A decision analysis was performed to see the effect of the three strategies, on 
the quality-adjusted life expectancy. 
The problem was modeled in the form of two phases. The first phase was 
modeled as a decision tree, beginning with a decision. The outcomes of that decision, 
depicted, surgery related mortality and accommodated, compliance to and adverse effects 
of prophylaxis against infection. The second phase was modeled as a Markov cohort 
analysis. But this didn’t serve the purpose of modeling the problem anywhere close to the 
reality, as the model represented a static situation in the first phase and hence, the 
dynamic element of the problem has been discarded. 
Static modeling, requires the decision model to solve the problem at any age, as if 
it were the only possible decision time, without considering the other decision time points 
and hence, that the decisions might be reconsidered later. Also, the model proposed by 
Marchetti et al. (1998) [45], allows, only one chance to take a decision and that too, 
immediately. 
Paolo Magni (2000) [8] modeled the above problem, by removing the two phases 
and as an MDP, using influence views. The influence views and conditional probabilities 
were fed to the DT-Planner (described above), to be solved by value-iteration technique 
and arrive at an optimal policy, which maximizes the quality-adjusted life expectancy of 
the patients. The results obtained, showed little improvement, when compared to the 
static model and hence, an issue of investigation. 
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Paolo Magni considerably simplified the HS problem, by making many 
assumptions, many of which were far from reality. Also, the MDP model doesn’t seem, 
either appropriate or accurate. Also, the calculation and consideration of the utility 
values, which are in quality adjusted life years (QALY) is not very clear and convincing. 
As such, medical problems are complex and the case of HS, is one of them. It seems to us 
that proper modeling of this problem, as an MDP would result in a large state space, to 
the order of 9.12 * 105. But, the model by Paolo et al. has a total of 11 states. As the state 
space became dwarfed, the age-old dynamic programming algorithm (value-iteration 
technique) could be applied and solved for an optimal policy using the DT-Planner. 
However, for a large state space problem (as mentioned earlier in the introduction), 
value-iteration technique would take forever to solve and would barely help. 
Moreover, until now, in the literature, researchers have been modeling any kind of 
decision problem as an MDP and solving it with only the available value iteration 
technique.  
This situation challenges us and motivates to propose a methodology, which can 
model and solve any kind of medical decision problem, especially the ones with large 
state spaces. We choose the ever-interesting HS problem for our research, summarized in 
the following chapters. 
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CHAPTER 3 
 
RESEARCH OBJECTIVES 
 
 
In this chapter, the problem of Hereditary Spherocytosis and its symptoms are 
described, and the research objectives are stated. 
3.1 Problem statement 
The problem under consideration is the Hereditary Spherocytosis (HS), which is 
the most common erythrocyte membrane disorder. Patients with this disease, suffer from 
a chronic destruction of red blood cells. It is known, that in 60% of the cases, the disease 
is severe and the patients become extremely anemic. In the rest 30% of the cases, the 
patients are mildly anemic, with a hemoglobin level over 11 g/dl, a reticulocyte count of 
3-6% and a bilrubin level of 1-2 mg/dl. These patients have an increased risk of gallstone 
formation, because of the sustained erythropoesis, which predisposes them to episodes of 
parvovirus induced aplasia and haemolytic crisis. 
In the severely anemic patients, performing surgery, called splenectomy and 
removing the site of red blood cell destruction is mandatory. But, in the case of mildly 
anemic patients, there is no necessity to perform splenectomy immediately. These 
patients have other treatment options available other than splenectomy. Thus, arises a 
decision problem for the physician. Keeping in view, the side effects of splenectomy and 
the availability of other treatments, the physician gets into a dilemma as to which would  
be the best decision. He/she has to trade-off between, preventing adverse disease 
consequences, and the risks posed by surgery, including, mortality, morbidity and post
 32
splenectomy infections. The other available treatments would comprise of no surgery, 
where the patient is not treated but kept under observation to intervene at a later point of 
time and the laproscopic cholycystectomy, which can prevent gallstone formation. 
Therefore, the decision problem consists of coming up with the optimal 
therapeutic plan, which dictates, depending on the patient’s condition, what surgery 
should be performed, when it should be performed and in what condition can it be 
performed, to maximize the quality of life of the patient under consideration. 
3.2 Research objectives 
The objectives of this research are the following, 
T to propose a methodology, which accommodates the modeling of the sequential 
decision problems in medicine, as a MDP, and, to use a computer simulation 
based reinforcement learning algorithm for an efficient solution, 
T to model the HS disease problem as a MDP and to obtain the results by solving it 
using the proposed algorithm, 
T to compare the results obtained by the proposed methodology algorithm, with the 
results obtained using dynamic programming algorithm. 
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CHAPTER 4 
PROBLEM FORMULATION AND SOLUTION METHODOLOGY 
 
 
The Hereditary Spherocytosis problem has been formulated as a MDP. This 
chapter describes in detail, the issues of modeling the problem as a MDP and its solution 
methodology using a reinforcement learning algorithm. The simulation mechanism 
involved and the ‘average reward reinforcement learning’ algorithm are also presented. 
4.1 Problem formulation 
Let the system state of a patient be described by the vector ‘s’. The system state 
consists of the basic variables necessary to describe the patient’s state. These can be 
called as the state variables and in every decision epoch, the physician chooses an 
optimal action based on the current state of the patient. The important elements of the 
patients’ state are the following variables. 
T Presence of gallstones 
T Presence of spleen 
T Presence of sepsis 
T Time elapsed after splenectomy is done (in years) 
T Presence of complication 
T Age and sex of the patient
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Therefore, the system state vector can be written as 
 s = (g, s, s~ , t, c, a, ),                      (4.1) sˆ
where, 
T g, describes the state of gallstones, 
T s, describes the presence or absence of spleen, 
T s~ , describes the presence or absence of sepsis, 
T t, describes the elapsed time after the surgery splenectomy is performed, 
T c, describes the presence or absence of a complication, 
T a, describes the current age of the patient at that particular decision epoch, 
T , describes the sex of the patient. sˆ
The underlying Markov chain of the MDP can be denoted by  
{ },,: ξ∈∈= nn SNnSS                                                          (4.2) 
where, 
T , denotes the system state at the nnS
th decision epoch, 
T n, of the decision epoch index, 
T ξ  , denotes the state space, 
T N ∈  { }  .100,....,3,2,1
(See Appendix A for a detailed description of a MDP). 
At any decision epoch n, nS ∈ξ  and the action is chosen as an ∈  A(s), 
where, A(s) denotes the set of all possible actions in a state ‘s’. 
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4.1.1 Elements of the MDP 
The five important elements of an MDP are defined below for the problem under 
consideration. 
4.1.1.1 State space 
The values associated with the state variables are as follows, 
T g = {1, 2, 3, 4, 5, 6}, 
T s = {0, 1}, 
T s~  = {0, 1}, 
T t = {0,1, 2, ….95}, 
T c = {0, 1, 2}, 
T a = {1, 2, ….100}, 
T s~ = {0, 1}. 
Therefore, the cardinality of the system state space ξ  is  
|ξ | = 6 * 2 * 2 * 95 * 3 * 100 * 2 ≈13.68 ×  105. 
Total number of states in the associated transition probability matrix = 187.1424 * 1010. 
4.1.1.2 Action space 
The action vector is given as A = (a1, a2, a3, a4, a5) where, ai, i ∈  {1, 2, …5} 
denotes the five intervention strategies. Every year, the physician can choose among the 
following strategies. 
T a1,  no prophylactic surgery 
T a2,  prophylactic splenectomy 
T a3,  prophylactic cholycystectomy 
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T a4,  prophylactic splenectomy and prophylactic cholycystectomy 
T a5,  open surgery (in the case of a complication occurring due to gallstones) 
Not all of these five action choices, though, are available for every state. Therefore, the 
availability of these actions depends on the state in which the patient is present. 
4.1.1.3 Time horizon 
In the present model considered, the maximum life span of a patient is assumed  
to be 100 years. However, from every state s ∈  ξ , there is a nonzero probability of 
natural death for the patient, apart from the probability of treatment related death 
associated to certain states. Therefore, a patient is assumed to live for 100 years or less. 
4.1.1.4 Decision epoch 
The time between two decision epochs is considered to be 1 year. It is assumed 
that a patient visits the doctor every year and the patient state is observed every year. 
Therefore, the normal life span of a patient in years would equal the number of finite 
decision epochs the Markov chain evolves through before reaching the state of death. 
However, the quality adjusted life years that the patient enjoys is calculated using the 
utility function and is different from the normal life span. 
4.1.1.5 Transition probabilities 
For every action ai ∈  A, there is a transition probability matrix P (ai) of the 
Markov chain S, where  represents the probability of moving from state s to (s a′ )isP S ′  
under action ai. These transition probabilities can be obtained from domain experts or 
abstracted from medical databases. Transition probabilities are assumed to be stationary. 
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4.1.1.6 Rewards 
To obtain the best strategy, there has to be some measure of an action’s value, so 
that one can compare different actions. Hence, an immediate value is specified for 
performing each action in each state.  
Given the system state s at decision epoch n and action ai, if the next state is s′ , 
the expected value of the reward is 
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The rewards can be in any unit of interest. For example, monitory cost, lifespan or cost-
effectiveness ratios etc. The rewards are considered here as the Quality Adjusted life 
Years (QALY) of the patient. 
4.1.2 Quality adjusted life years (QALY) 
The following sections describe quality of life adjustment, define a QALY and 
explain various methods to derive quality weights for health states. Then, the proposed 
method to obtain quality weights for health states is discussed. Finally, the procedure of 
obtaining immediate rewards in terms of QALYs has been explained. 
4.1.2.1 Utility function 
The utility function used to compare the different strategies is based on the 
Quality Adjusted Life Years (QALY) concept. Quality of life adjustment, measures the 
degree to which surgical interventions, medical therapies and disease states diminish the 
well being of patients. It is expressed as a number between 0 and 1, for every health state. 
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The physician’s decision, coupled with the inherent changes occurring in the health of a 
patient, can lead the patient to a decrease or increase in his/her quality adjusted life years. 
A patient’s QALYs are observed every year, until the patient dies and the overall gain or 
loss in QALYs is calculated. Thus, the objective function considered, is to maximize the 
gain of the QALYs over the patient’s whole life. Hence, the utility function considered in 
this thesis is based on the QALY concept. The assumption involved associating the value 
function, concerning the utility is that, it is time separable. This implies, that it would be 
possible, to calculate the overall value or the utility function as a combination of 
functions, specified at each decision epoch. 
4.1.2.2 QALY 
According to Joshua graff Zivin (2002) [52], economists prefer to measure any 
physical quantity in terms of their monitory value. But, health economists didn’t prefer 
such a method because of the general belief that life is too precious to be priced, or that, 
such a pricing is morally unacceptable. Therefore, health economists relied on other 
methods, which measure the benefits from any health related activity that affects health, 
in units of health outcomes. These units could be blood pressure units, cases of a 
particular disease or life years. That’s how, quality-adjusted life years emerged as a 
measure for health related outcomes. 
Anytime when one talks about the outcome of a treatment or anything which 
effects the health of a person, there are always two issues involved. One is the ‘quantity’ 
of life of the person affected because of the intervention and the other is the ‘quality’ of 
life of the person, which measures not the number of years a person lives, but measures 
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the years, which he/she lived comfortably with perfect health. The problem with using 
only quantity of life as a measure is that it only considers whether people are alive or not 
and is often expressed as life expectancy. On the other hand, quality of life takes care of a 
number of issues concerning people related to their physical and mental capacity coupled 
with the emotional aspects. Formally, a measure of quality of life is a quality adjusted life 
year.  In mathematical terms, it can be expressed as,  
QALY = Life Expectancy x Quality of the remaining life years. 
The quality of the remaining life years is quantified by placing a weight on time in 
different health states. The concept of QALY provides a common basis to compare the 
different kinds of interventions in terms of health related quality of life.  
The idea of QALY is explained in brief below with the help of an example. 
Suppose, a physician is trying to decide between two treatment strategies. Treatment A 
has more probability of treating the disease than treatment B, but A leads to side effects 
whereas B, has no significant side effects. Then, to compare the benefits of the two 
treatments, the physician needs to know more than just the probability of success of each 
treatment or life years saved. He/she should also know the amount of value which people 
place on the health state with side effects related to the treatments, the quality weight for 
the health state with side effects. This quality weight is also sometimes referred to as the 
utility value of that particular health state. Suppose, the quality weight for the state with 
side effects was estimated to be 0.75 (i.e.,) one year with side effects is equivalent to 9 
months in perfect health. And if treatment A yields a total of 10 extra life years, then it is  
 40
said that treatment A yields 0.75 ×  10 = 7.5 QALYs. This figure would then be 
compared to the QALYs generated from treatment B to determine which yields greater 
benefits. 
4.1.2.3 Methods for deriving quality weights for health states 
 Research on the subject provides different methods to generate the quality of life 
values or the quality weights, by observing the health states of the patients. These are also 
often referred to as preference weights or utility values of the states. The methods to 
obtain these weights fall into two broad categories. First category comprises of , 
T rating scale technique, 
T standard gamble technique, 
T time trade off method. 
Second category comprises of the multi-attribute health states survey. 
 The methods in the first category directly assess the quality weights with the help 
of preferences of the individuals for well-described health states. Here, individuals are 
asked to rank the given health state, relative to death and perfect health. The way of 
ranking the health states differs from one method to the other. The second category 
methods break down all the health states into a set of primary quality attributes, which 
characterize those health states. Individuals are then asked to fill questionnaires designed 
specially for the purpose. These multi-attribute survey answers are transformed into 
quality weights using the first category techniques.  
 Below given is a brief description of the methods in the first category as explained 
by Joshua graff Zivin.  
 41
4.1.2.4 Rating scale 
In this method, individuals are provided with a set of health states and are asked 
to select the best and worst of those states. Then, those two states form the minimum and 
maximum rating on a scale, usually the best being 1, and the worst state taking the value 
zero. All the other states are placed on the scale according to the rating of the individual. 
After this the respective ratings of the states are converted into quality weights of the 
respective health states. 
If, death is the worst state, 
teossibleStaOfTheBestPScaleValue
hStateOfTheHealtScaleValueghtQualityWei
tenHealthStaForAnyGive
=  .                                               (4.5) 
 
If, death is not the worst state,  
yz
yxghtQualityWei
tenHealthStaForAnyGive −
−= ,            (4.6) 
 
where, x = Scale value of the health state, 
 z = Scale value of the best state, 
 y = Scale value of death. 
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Figure 5. Rating scale for quality weights 
 
4.1.2.5 Standard gamble 
 In this method, the subject is asked to choose between two alternatives. The first 
alternative has two possible outcomes. 
T Perfect health state of quality weight 1, for a length of time ‘t’ 
T Immediately going to worst state of quality weight 0 
The second alternative is living in the same imperfect health state for a time ‘t’ with 
certainty. The probability of perfect health is denoted by ‘p’ and the probability of going 
immediately to worst state is denoted by ‘ p−1 ’. ‘k’ denotes the probability of being in 
imperfect state. The quality weight for state ‘imperfect health’ is determined by varying 
the probability ‘p’ until the subject is indifferent between the two alternatives. The weight 
for state ‘k’ is equal to the value ‘p’.  
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Figure 6. Standard gamble for deriving quality weights 
This technique has got the uncertainty element in it. The quality weights are determined 
by the risk of going to a worse state, that an individual is willing to accept to get an 
improvement in his/her health. 
4.1.2.6 Time tradeoff 
This also, has two alternatives for the subject to choose from. Alternative 1 is life 
in imperfect health state ‘k’ for time ‘t’ and then death. Alternative 2 is perfect health for 
time ‘y’ and then death. But, t >y. time ‘y’ is varied until the subject is indifferent 
between the two alternatives. 
=''keghtForStatQualityWei  
t
y .          (4.7) 
The aim of this method is to determine the amount of life expectancy an individual is 
willing to sacrifice to increase the quality of their health. 
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4.1.2.7 Multi-attribute health status surveys  
In this method, the health states are characterized by important health attributes. 
For example, the EuroQol system contains five attributes, namely, mobility, self-care, 
anxiety/depression, pain or discomfort and usual activities. These attributes further have 
levels, from which the subject chooses, according to the health situation. Under mobility, 
for example, the subject can choose from,  
T no problems walking, 
T some problem waking, 
T confined to bed. 
Then, these levels, which the subject chooses according to the health condition, are 
transformed into quality weights in two steps. First step involves, determining a method 
for aggregating the attributes and specification of a multi-attribute utility function.  
Second, a large number of people are given questionnaires, which are designed to 
incorporate all the attributes and the people are supposed to check the attributes with 
which the health state can be defined. The same population is also asked to weigh the 
health state using the standard gamble or the time tradeoff methods. Then, the two sets of 
quality weights of health states are used to estimate the parameters of the multi-attribute 
utility function. In the end, the result is a set of quality weights for all the possible 
attributes and levels in the questionnaire, allowing any pattern of answers to be assigned 
into a single quality weight that is bounded between 0 and 1. 
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4.1.2.8 Cost-utility ratios 
When the QALY values are combined with the costs of the interventions, cost-
utility ratios can be obtained which can be used as another measure for differentiating 
between interventions. 
Mathematically, 
nBnterventioOfQALYsByINonAnterventioOfQALYsByINo
rventionBCostOfInterventionACostOfInteRatioCostUtilty
.. −
−= .     (4.8) 
These ratios indicate the additional costs required to generate a year of perfect health 
(i.e.,) one QALY, through an intervention. 
Though, all these methods are available to determine quality weights to the health 
states, they all involve, a population of subjects. In the present thesis, because of lack of 
access to actual individuals suffering from HS and also due to lack of resources for 
conducting statistical surveys over a population of subjects, the above mentioned 
methods cannot be followed to obtain quality weights. However, a method has been 
developed for the purpose, which produces quality weights that are most consistent with 
the health states involved in the model. This method is more on the lines of the multi-
attribute survey technique. This has been developed to obtain the quality weights, so that, 
the proposed methodology can be checked for validity. Nevertheless, the methodology is 
capable of incorporating quality weights obtained by any method available. 
 Research in area of ‘evidence based medicine’ is exploring ways to come up with 
consistent mathematical methods to measure quality of life. For example, Bernard M. S. 
van Praag and Ada Ferrer-I-Carbonell (2001) [53], discuss how QALY losses can be 
assigned to various impediments and illenesses. A mathematical methos has been 
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proposed to calculate the QALYs based on the age of the person and the results of the 
paper shoe that the method is operationsl to evaluate the health situations of populations 
and population subgroups. Nevertheless, the use of QALYs in decision-making does 
mean that the different kinds of interventions are being distinguished from each other and 
the differences between them made explicit. 
4.1.2.9 Limitations of QALYs 
QALYs are a mere indication of the benefits of a particular intervention. These 
values could be far from being perfect as a measure of outcome. The following are some 
of the limitations of QALYs, 
T lack of sensitivity when comparing two similar drugs, which are competitive, 
T preventive measures where the impact on health outcomes may not occur for many 
years may be difficult to quantify using QALYs, 
T QALYs are highly dependant on age and life responsibilities. For example, it is 
difficult to compare an athlete’s ankle fracture with that of a young boy, who have been 
restored to some degree of mobility, 
T definition of perfect health is highly subjective. 
Nevertheless, this procedure can aid anyone, wanting to use the system, at least in 
prioritizing their expenditure, while choosing from a variety of interventions. New 
techniques and therapies are bringing in much complexity for the health care  
professionals as to which strategy to choose. Therefore, the concept of QALY and cost 
utility ratios provide additional information, thus aiding the health care professionals in 
decision-making. 
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4.1.2.10 Uses of QALYs 
The concept of QALY is used more as a comparison tool. 
T It can be used to identify public health trends for therapies to be developed 
T To assess the effectiveness of health care interventions 
T To determine state of health in communities 
4.1.2.11 Method followed to derive quality weights for health states 
As mentioned earlier, the method followed in the present thesis, to derive quality 
weights to health states is similar to the multi-attribute method described. The health state 
of the patients with HS can be characterized by the five attributes, namely, gallstones (g), 
spleen (s), sepsis ( s~ ), time (t) and complic (c). Further, these attributes have their 
respective levels. Because of lack of resources and time, a statistical survey has not taken 
place with the help of questionnaires. Nor, was there any sort of input from general 
population regarding quality weights using standard gamble or the time tradeoff methods. 
Hence, the parameters of the multi-attribute utility function are not estimated by 
comparing the answers from the general populace, but are assigned some arbitrary values. 
These values, though arbitrary, are consistent in deriving a set of quality weights for each 
possible level chosen, according to the state of the patient, thus allowing any pattern of 
answers to be aggregated into a single quality weight that is bounded between 0 and 1.  
The consistency involved in obtaining the weights for all the health states involved in this 
model, makes it promising to use in the present modeling methodology and to check its 
validity. 
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 This method is further described in detail. The different attributes and their 
respective levels, along with the arbitrary values, which they yield, have been shown in 
Table 1. Depending on the health state, values are attained for all the five attributes, 
according to their respective levels. These values are then summed up to arrive at the 
quality weight of that particular health state. In this manner, the quality weights for all the 
states (2685) have been derived. 
Example 1 
The quality weight for the health state s (3,1,0,0,1) would be (from Table 1) 
0.15 + 0.0 + 0.10 + 0.05 + 0.0 = 0.30. 
Example 2 
The quality weight for the health state s (2,0,1,5,0) would be  
0.20 + 0.30 + 0.00 + 0.0026 + 0.30 = 0.803. 
Table 1. Quality weights 
Note: All values are in generic units 
 Attribute Level Description Level Value  
Gallstones No Gallstones 1 0.22 
 Asymptotic Gallstones 2 0.20 
 Occasional colics 3 0.10 
 Recurrent Colics 4 0.07 
 Gallbladder removed 5 0.15 
 No Gallstones (Death) 6 0 
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Table 1. (Continued) 
 
Attribute Level Description Level Value  
Spleen Present 1 0 
 Absent 0 0.22 
Sepsis Present 1 0 
 Absent 0 0.23 
Time  Splenectomy not done  0 0 
Time (if 
sepsis = 0) 
Splenectomy done  1 year 2 * 0.15625 
 Splenectomy done  2 years 3 * 0.15625 
 Splenectomy done  : years :   * 0.15625 
 Splenectomy done  : years :   * 0.15625 
 Splenectomy done 95 years 96 * 0.15625 
Time (if 
spleen = 1) Splenectomy done 
1 year 15 
 Splenectomy done 2 years 15 – (1 * 0.15625) 
 Splenectomy done 3 years 15 – (2 * 0.15625) 
 Splenectomy done :  years 15 – ( : * 0.15625) 
 Splenectomy done :  years 15 – ( : * 0.15625) 
 Splenectomy done :  years 15 – (94 * 0.15625) 
Complic Present (due to 
gallstones) 
1 0 
 Present (due to spleen) 2 0 
 Absent 0 0.18 
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4.12.12 Immediate rewards in terms of QALYs 
The immediate rewards obtained are in terms of QALYs, when a state transition 
occurs. Suppose, if a patient is in state 1, with quality weight 0.3 and an intervention 
takes place. Due to the effect of the intervention, coupled with the body’s natural 
metabolic rate, if he is found to be in state 2, with quality weight 0.8, then it is believed, 
that the patient led the one year period within a health state of quality weight of 0.8 – 0.3 
= 0.5. If the patient were to continue in state 1 for the one year period, without transiting 
to state 2, because of the intervention, then the QALYs he would have enjoyed, would be 
0.3  1 year = 0.3 QALYs. Another perspective can be the one of the patient to be in 
state 2, right from the beginning, for the one-year period. Then, his QALY would have 
been 0.8 ×  1 year = 0.8 QALYs. But, in the case of the patient’s transition from state 1 to 
state 2, he gained some quality weight owing to the transition, which occurred due to the 
intervention. Thus, he gained 0.5 QALYs by transiting from a state, which provides 0.3 
QALY’s to a state, which provides 0.8 QALYs. This gain in the QALYs is considered as 
the immediate reward, due to the respective intervention.  
×
These immediate rewards are aggregated to get the total expected reward, at the 
end of the Markov cycle, which here, is indicated by the death of the patient. Hence, the 
objective function, here, is to maximize the gain in the QALYs of a patient. These, total 
expected rewards obtained for each patient is compared and the patient whose total  
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expected reward is the highest, is selected. The policy, followed by that patient, becomes 
the optimal policy, which dictates what action to be taken in what states, such that the 
gain in the QALYs is maximized. 
4.1.3 Hereditory spherocytosis 
In this section, more details of the Hereditory Spherocytosis along with some 
assumptions are given. This information is needed for simulating the treatment process. 
4.1.3.1 Spleen 
Spleen is the red-blood cell destruction site (detailed in the problem description), 
which can be removed with the help of surgery. The presence of spleen poses an 
increased probability of gallstone formation. The absence of spleen causes a high risk of 
infectious condition known as sepsis. The incidence of sepsis depends on the length of 
time, since the spleen has been removed by the surgery splenectomy. Less risk has been 
associated for sepsis formation, of less than or equal to 4 years of spleen removal. More 
risk is associated for the formation of sepsis, after 4 years of spleen removal. Spleen can 
be removed with the help of surgery. At each decision epoch, a patient without spleen 
will remain in the same situation, that is without spleen and a patient with spleen also 
shall remain in the same condition, unless an action is taken to intervene the condition. It 
is assumed that a patient visiting the doctor for the first time, would not have undertaken 
any kind of prior treatment, or would not have undergone any surgical procedure relating 
to his/her disease. 
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4.1.3.2 Gallstones 
The gallstone history of a typical HS patient can be classified as follows. The 
gallstones state variable has been assigned levels depending on the state of gallstones of 
the patient. The corresponding levels are shown in parenthesis below. 
T Patients without gallstones (level 1) 
T Patients with asymptotic gallstones, i.e. gallstones found through ecography but 
without clinical procedures (level 2) 
T Patients with gallstones and occasional biliary colics, i.e. less than three episodes in 
the last year (level 3) 
T Patients with gallstones and recurrent biliary colics, i.e. more than three episodes in 
the last year (level 4) 
T Patients without gallbladder, because it has been removed (level 5) 
T Patients who are dead  (level 6)  
Hence, the gallstone state variable takes the values from 1-6. After each decision epoch 
of the Markov chain,  
T a patient can remain in the same state of gallstones, 
T can develop asymptotic gallstones, 
T can develop occasional biliary colics or recurrent biliary colics, if he/she 
already has asymptotic gallstones, or 
T can develop recurrent colics if he/she has already occasional colics. 
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Gallstones cannot develop if the gallbladder has been removed. A transition diagram of 
the gallstones is shown in Figure 7. Gallstones can be removed with the help of surgery. 
It is assumed that the presence of spleen increases the risk of gallstone formation. 
 
 
 
 
 
 
 
 
 
No Gallstones 
Asymptotic Gallstones 
No Gallstones 
(Gall bladder 
removed)
Occasional colics Recurrent colics 
No Gallstones (Death)
 
Figure 7. State transition diagram for gallstones 
4.1.3.3 Sepsis 
The patients at any point of time can be classified on the basis of sepsis as, 
T patients who developed sepsis (level 1) and, 
T patients without sepsis (level 0). 
As mentioned previously, the condition of sepsis occurs only when spleen is absent in a 
patient and the risk of sepsis formation is dependant on the time elapsed after the spleen 
removal by splenectomy. It is assumed that surgery cannot be done if a patient develops 
sepsis.  
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4.1.3.4 Time 
The time that elapses after the surgery splenectomy is kept in track. As said 
before, there is less risk of formation of sepsis within 4 years of doing splenectomy and 
more risk after 4 years. Therefore, in the simulation of the proposed framework, this issue 
has been taken into account to give an idea as to how much time (in years) has elapsed 
since splenectomy was done and accordingly, the risk of sepsis in the form of 
probabilities has been assigned to the transitions occurring from one patient state to 
another.  
The assumptions here are that splenectomy can be done only for patients who are 
5 years of age and above. Assuming that a person’s life span is 100 years, the time state 
variable can take values from 5-100. After splenectomy is done, from then on, at every 
decision epoch, the time state variable is incremented by a value of 1 indicating the 
number of years that elapsed after the removal of spleen through splenectomy. Thus, the 
value of the time state variable depends on the value of the spleen state variable. If spleen 
shows a value of ‘1’, that definitely is an indication that the time value is ‘0’. 
4.1.3.5 Complications 
This variable keeps track of any complication in a patient. This could be any type 
of complication, meaning any type of situation requiring immediate intervention. 
Complications can be of mainly two kinds. 
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T Complication occurring due to the presence of gallstones denoted by the 
complic (c) variable taking the value 1 
T Complication ccuring due to the presence of spleen denoted by the complic (c) 
variable taking the value 2. 
The condition of ‘no complication’ is denoted by a value zero taken by the complic (c) 
variable. Acute cholecystitis and biliary pancreatitis are examples of complications due to 
gallstones for which, an opensurgery may be required. Aplastic crisis is an example of 
complication occurring due to spleen, for which splenectomy is the remedy. The 
outcomes of the surgeries could be, that the patient is out of complication, implying that 
the value of the state variable ‘complic (c)’ is turned to ‘0’.  Another outcome of the 
surgery could be surgical death, in which case also the ‘c’ variable takes the value of ‘0’. 
When, complication is present, the value assigned to ‘c’ is 1.  If there is no complication 
in the current patient state, then the risk of occurrence of a complication in a future 
transition state is dependant on the level of the gallstone state variable. As the level of the 
gallstone variable increases, the probability of occurrence of complication increases. 
When the level of gallstone state variable is 5 or 6, the complication variable (c) takes the 
value ‘0’ in the next state, since for gallstone at level 5, no complication can arise as the 
gallbladder has been removed. For gallstone in level 6 no complication can arise, as it 
indicates death. If the complication value in the current  
patient state is ‘1’, then a surgery is mandatory and the complication would have been  
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removed in the next transition state. Then, the transitioned state would definitely have a 
‘c’ value of ‘0’, concerning that particular complication, concerning that particular 
complication. 
4.1.3.6 Age 
The decisions that a physician make might alter according to the age of a patient. 
Therefore, age is an important state variable. This state variable can take the values from 
1 to100, assuming that patients can be in the range of one to hundred years old. After 
each decision epoch of the Markov chain, the age state variable is incremented by 1. 
Age is not taken into consideration, as a state variable in the proposed simulation 
mechanism, due to the lack of knowledge of how the domain experts change their 
decisions depending on the age. But, the idea is that, age should be incorporated into the 
MDP modeling as a state variable, as it would differentiate the state of a patient 
depending on the age unlike the model of Paolo Magni et al.(2000)[8]. This variable if 
incorporated would contribute considerably to the state space of the system. 
Though, age is not considered a state variable, it is taken into account in the 
present model, while dictating the optimal policy to the doctor who takes help of the 
decision support system. This is achieved by obtaining different optimal policies, 
according to the age of the patient. Usually, one optimal policy is obtained for a problem, 
but here, when age is taken into consideration, patients of different ages, become 
different optimization problems. The reason being, the maximum number of decision 
epochs, which can be traversed by different age patients are different. Though, the  
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methodology remains the same, it has to be applied, separately, to the different age 
patients to arrive at the respective optimal policies. Thus, age contributes to the decision 
making. 
4.1.3.7 Sex 
While resolving the tradeoff between the decisions to be taken, sex could be an 
important factor. Hence, it is appropriate to be added as a state variable denoting the 
patient state. This variable can take the values of ‘0’ for male and ‘1’ for female patients. 
However, the value of this variable remains the same through the decision process.  
Sex also, has not been incorporated in the model due to lack of knowledge to 
approximate the behavior of the system based on this variable. In this thesis, sex has been 
taken into account in the model building process , but not while simulating the model.  
4.2 Model solution 
The solution to an MDP is called a policy and it simply specifies the best action to 
take for each of the states. 
4.2.1 Simulation mechanism 
The program ‘Medical decision making’ written in Java 2.0 programing language 
simulates a patient arrival and assigns a starting state to the patient. After an action is 
chosen, the patient goes to a transitioned state, from among a possible set of transition 
states. A reward or utility is generally assigned for that particular action, which is called 
the immediate reward. At the transitioned state, the decision maker again chooses an  
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action and the patient makes yet another state transition. This cycle continues  until the 
patient dies or reaches the age of 100 after which the model assumes that patient is no 
more. 
The states and the actions taken in those states, until the patient’s death are noted. 
Also, the immediate rewards and the total expected reward are noted. Thereafter the 
model generates a new patient with a starting state and the cycle repeats.  
The above-mentioned procedure is followed for a particular age group of patients. 
The optimal policy obtained, also pertains, only to this age patients. Thus, different 
optimal policies have to be obtained for different age patients. The methodology to obtain 
the optimal policy, though, remains the same. 
4.2.1.1 Assignment of the starting state 
Considering the present problem of HS, the starting states where a patient can 
begin the simulation, which corresponds to the situation of the patient when a doctor for 
the first time examines him/her, are found to be eleven. Equal probability is assigned for 
the patient to start in any of these 11 states. It should be recollected that the total state 
space is 2685 (including death states). 
4.2.1.2 Input parameters 
The action to be taken in a particular state is dictated by the reinforcement 
learning algorithm. When that action is performed in the respective state, the transitioned  
state to which the system moves is obtained by simulating that action in that state, in the 
simulation mechanism. This cycle repeats until the patient dies and the rewards are 
collected. 
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The numbers fed to the simulation program, which are the associated probabilities 
of going from one state to other, can be changed according to the user’s knowledge 
pertaining to the information of his/her HS patients. These numbers could also be  
obtained from a medical database using tools like data mining or Bayesian learning. 
However, the methodology remains the same and the simulation-based reinforcement 
learning mechanism can work for any numbers, obtained in any manner. 
The reinforcement learning algorithm developed in this research, to obtain the 
optimal policy, which maximizes the QALY’s of a specific age patient, is presented next. 
4.2.2 Average reward reinforcement learning  
Here, the detailed steps of the algorithm are presented. This algorithm is a 
modified form of the algorithm given by Gosavi (1999) [46], adapted to the medical 
decision making problem considered, keeping in view the objective of maximizing the  
QALYs. 
4.2.2.1 RL algorithm 
1. Let the iteration count m = 0.  
Initialize a new patient arrival and assign a state(s) to the patient. 
Initialize action values Q(s,a) = 0 for all s∈ξ  and a∈A(s), and the average 
reward   0=ρm   , 
Initialize input parameters ( ),)(,)(, ttt γγββαα , 
where,  α represents learning rate, 
   β  represents average reward rate, 
   γ  represents the exploration rate. 
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2. While m < MaxSteps, do. 
If the system state at iteration m is s∈ξ , 
a) With a probability of ( )γ m−1 , choose an action a∈A(s) in state s, 
corresponding to the maximum Q(s, a). 
Otherwise choose a random exploratory action from 
{A(s)} with probability  
)1|)((| −sA
mγ . 
b) Simulate the chosen action a for the current state s. 
Let the system state at the (m+1)th decision epoch be s′ . Let 
the immediate reward be R (s, a, s′ ).  
c) Update the Q(s, a) value using the following equation 
)](),,([),()1(),( exp sQsasRasQasQ mmm ′+−′+−← ραα .     (4.9) 
d) Update the average reward ρ 1+m  value as follows, 



+
′+×+−←+ 1
),,())(1(1 m
sasRm
mmmmm ρβρβρ .                (4.10) 
e) Update the learning parameters βα 11, ++ mm and the exploration parameter 
γ 1+m  following the Darken-Chang-Moody (1992) [47] scheme. 
For any parameter θ with θ0 as its initial value and θt as the decay control 
parameter, updating is done as follows, 
um +=+ 1
0
1
θθ   ,                               (4.11) 
where,  
)(
2
m
mu
t += θ  .                                             (4.12) 
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The elements α , β  and γ  are the starting values, and tα , tβ , tγ  are 
large constants chosen suitably to control the learning and decay rates. 
f) Set current state s to new state s′ , and m ←  m+1. 
3. If MaxSteps is reached, then go to step 4. 
Else, if  is the death state, then initialize a new patient arrival having a 
starting state and go to step 2a. 
s′
 Else, go to step 2a.  
4. Simulate the system with the final form of the Q-matrices to estimate the average 
value of the total QALY. 
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CHAPTER 5 
NUMERICAL RESULTS  
 
 
In this chapter, the numerical results obtained by applying the proposed solution 
methodology to the hereditary spherocytosis problem are presented. The solution 
methodology was tested with different values of the algorithm design parameters. The 
results presented represent the best solution. 
5.1 Reinforcement methodology results 
The solution methodology requires six design parameters. The design parameters 
are the initial values of the learning parameters (α , τα ) for the Q-Values, learning 
parameters ( β , τβ ) for the average reward ρ , and the exploration parameters (γ , τγ ). 
The parameters τα , τβ  only affect the rate of decay of the corresponding learning 
parameters and are initialized to a large value of 1012. The exploration decay parameter, 
τγ  effects the rate at which exploration occurs and is initialized to 1011. The average 
reward obtained from the RL methodology for various values of the exploration 
parameter (γ ) and a fixed set of values for the learning parameters are listed in Table 2. 
The fixed values of the learning parameters (α , β ) were obtained by trial and error. 
 Figure 8 shows a plot of the number of decision epochs versus the average reward 
obtained in each decision epoch during the learning phase of the RL methodology         
for different exploration parameter values, keeping the learning and the average reward 
learning parameters at a fixed value of 0.1. 
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Table 2. Results from the RL methodology 
S. 
No 
γ  Avg. QALY/year 
Learning Phase 
 
Avg. Total QALY 
Learnt Phase 
 
1 0 0.4356092 41.56283 
2 0.1 0.4170014 41.37534 
3 0.2 0.4346187 41.54974 
4 0.3 0.444321 41.49474 
5 0.4 0.4026054 41.15621 
6 0.5 0.4007282 41.61528 
7 0.6 0.390321 41.53495 
8 0.7 0.4524216 41.95321 
9 0.8 0.4392717 41.82469 
10 0.9 0.4106183 41.32438 
QALY = Quality adjusted life years 
Note: All values are in generic units 
Fixed values of the learning parameters (α , β ) = (0.1, 0.1) 
Fixed values of the learning decay parameters ( τα , τβ  ) = E12 
Fixed value of the exploration decay parameter ( τγ ) = E11 
 
 
 
 
 64
Learning Phase Avg. Rwd
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Figure 8. Average reward values for different exploration parameter values 
The third column in Table 2 is the average reward in QALYs obtained for a 
patient in one year. This reward is obtained as a consequence of the decisions made 
during the learning phase of the RL methodology.  The last column in Table 2 shows the 
average total QALYs per patient during his/her life time, which is the objective of the 
proposed methodology. These values are also called as the learnt phase values, because 
while obtaining these values, the RL methodology uses the best policy obtained in the 
learning phase. The corresponding combination of the design parameters associated with 
the highest learning phase average reward value would give the optimal solution. Thus, 
the highest average reward obtained during the learning, phase is  41.95321, 
corresponding to an 1.0=α , 1.0=β , 7.0=γ , τα & 12E=τβ , 11E=τγ . Hence, it can 
be concluded that, the quality life that patients suffering from HS enjoy, would be, on an 
average, around 42 years, assuming that the patient lives for 100 years unless he/she 
encounters a surgical death or death due to side effects of a performed surgery.   
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5.2 Value iteration approach  
According to Sutton and Barto [49], the term “Dynamic Programming” refers to a 
collection of algorithms that can be used to compute optimal policies given a perfect 
model of the environment as an MDP. 
Value Iteration is one such algorithm, which takes the transition probability 
matrices of different actions of the system and the reward matrix of the system as inputs, 
to compute the values of each state in the state space. Based on these values, the 
algorithm outputs a best policy. The best policy is a vector consisting of the best actions 
to be taken in the respective states such that the reward over the long run is maximized. 
[Please refer Appendix A for a description of the value iteration algorithm]. 
In the present problem, neither the transition probabilities nor the rewards are 
explicitly available. These have to be computed from the available information of the 
respective outcomes of the state variables, and their quality weights. Computation of 
transition probabilities from the known outcomes of various situations of a particular 
medical problem is part of the ongoing research on medical decision support. In the 
present thesis, a method is followed to obtain the transition probabilities and rewards 
from the known possible outcomes of the different levels of the state variables. 
The method followed is explained below. 
5.2.1 Method to obtain transition probability matrices (TPMs) 
As mentioned earlier in section 4.1.1.5, there exists always a probability 
of moving from state s to )a(P iss ′ s′  under action ai. In the present problem, it should be 
noted that the states are characterized by the five state variables namely, gallstones(g), 
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spleen(s), Sepsis( s~ ), time(t) and complic (c). These variables further consists of levels. 
Therefore in the HS problem, there always exists a probability of moving from one state 
variable level to another level of the same state variable under action ai, in one decision 
epoch, which is 1 year. These probabilities can be obtained from domain experts or 
abstracted from medical databases. In the present thesis, reasonable values are assumed 
for these probabilities for the five variables and are shown below. These are called 
variable transition probabilities from this point forward. 
Table 3. State-variable transition probabilities in a decision epoch 
Variable Condition Variable 
Current 
level 
Variable 
Transition 
Level 
Variable 
transition 
Probability 
1 1 1 
2 0.4 
3 0.4 
2 
4 0.2 
3 0.6 3 
4 0.4 
4 4 1.0 
Spleen = 0 
5 5 1.0 
1 0.2 
2 0.4 
3 0.3 
Gallstone ‘g’ 
Spleen = 1 1 
4 0.1 
  2 2 0.2 
Variable Condition Variable 
Current 
level 
Variable 
Transition 
Level 
Variable 
transition 
Probability 
3 0.5  
4 0.3 
  
3 0.3 
  
3 
4 0.7 
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Table 2. (Continued) 
 
Variable Condition Variable 
Current 
level 
Variable 
Transition 
Level 
Variable 
transition 
Probability 
  4 4 1.0 
  5 5 1.0 
Gallstone=1 0 0 1.0 
0 0.97 Gallstone=2 0 
1 0.30 
0 0.93 Gallstone=3 0 
1 0.07 
0 0.90 Gallstone=4 0 
1 0.10 
Spleen 
=0 
Gallstone=5 0 0 1.0 
0 0.93 Gallstone=1 0 
 2 0.07 
0 0.88 
1 0.05 
Gallstone=2 0 
 
 
2 0.07 
0 0.83 
1 0.10 
Gallstone=3 0 
 
 
2 0.07 
0 0.78 
1 0.15 
Gallstone=4 0 
 
 2 0.07 
0 0.93 
Complication 
‘c’ 
Spleen=1 
Gallstone=5 0 
 2 0.07 
  1 1 1.0 Sepsis ‘ s~ ’ 
Spleen=1  0 0 1.0 
 Spleen=0  0 1 5-
(TimeValue-
1)*0.0534 
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Table 2. (Continued) 
 
Variable Condition Variable 
Current 
level 
Variable 
Transition 
Level 
Variable 
transition 
Probability 
Variable 
   0 0 100-[5-
(TimeValue-
1)*0.0534] 
 0 0 1.0 Spleen ‘s’  
 1 1 1.0 
Spleen=1  0 0 1.0 Time ‘t’ 
Spleen=0  TimeValue TimeValue+1 1.0 
Note: All values are in generic units 
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These variable transition probabilities are the transition probabilities associated 
individually with each of the state variables. But the transition probabilities required for 
the value-iteration algorithm are the transition probabilities of moving from state ‘s’ to 
state ‘ ’. Therefore, a method is followed to get the state transition probabilities by 
grouping the variable transition probabilities. A patient state ‘s’ is considered, which can 
be called the current patient state. All the possible states to which state ‘s’ can transition, 
under a particular action (a
s′
i) are figured out, depending on the state variable levels of the 
considered current patient state ‘s’. These possible states are called transition states. After 
that, the state variable levels of the current patient state are compared with the respective 
levels of the state variables of each transition state. The transition probability associated 
to transition from a particular state variable level of state ‘s’ to a different level of the 
same state variable of a transitioned state ‘ s′ ’ is noted from Table 4, which has been 
called as the variable transition probability. Similarly, the transition probabilities for the 
other variables are also attained from Table 4. All these variable transition probabilities 
are summed up. Then another possible transition state is considered and the sum of the 
variable transition probabilities for its variables is obtained. In this way, the sum of 
variable transition probabilities is obtained for all the possible states figured out. All these 
sums are again summed up, which can be called as the total sum. Out of the total sum, the 
percentage of the individual sums is calculated, which are the required transition 
probabilities from state s to all the possible transition states. 
In this way for all the 2685 states, under different possible actions, the transition 
probabilities have been obtained and a transition probability matrix for each of the five 
actions has been developed. The rows of each transition probability matrix represent the 
probabilities of going from a particular state to all the other possible states in one 
transition or one decision epoch, for a particular action.  
5.2.2 Method followed to obtain reward matrix 
To develop the reward matrix also, a similar method is followed. A patient state 
‘s’ is considered and all the possible transition states ate figured out. The immediate 
rewards obtained for transitions to each of the possible states are calculated using the 
quality weights method given in section 4.1.2.11 and section 4.1.2.12. Then the 
immediate rewards are multiplied with the respective transition probabilities of the 
transition states. An average is taken over the products of the transition probabilities and 
immediate rewards, to obtain the reward in QALYs of taking that particular action in the 
state ‘s’. In this way, the immediate rewards obtained for all the states over all actions are 
put in a matrix form, which is the reward matrix. The rows of this matrix are the states 
and the columns are the five actions. 
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The value iteration algorithm uses these TPMs and the reward matrix to compute 
the actions which give the maximum value in each of the states. Sutton and Barto define 
value of a state or action, as a function which estimate how good it is for the agent (here, 
patient) to be in a given state or how good it is to perform a given action in a given state. 
Sutton and Barto furthur explain that “how good” refers to the future rewards the agent 
(here, the physician) can expect to receive in the future, which depends on what actions 
are to be taken. After computing the maximum value in each of the states, value iteration 
algorithm forms a policy, which consists of the actions corresponding to the maximum 
value in each of the states. But, this need not be the optimal policy. This could be one of 
the policies from the policy space. Therefore, the algorithm tries to improve the policy by 
calculating the values for each of the states again. In other words, it updates the values of 
the states using the below given update equation, which is another form of the Bellman 
optimality equation. 



 ×+= ∑
=∈
M
0j
oldisa)s(Aanew
)j(V)a,j,s(pRmin)s(V
i
i
,                   (5.1)  
where, s is the current system state (here, patient state), 
 j is the transitioned system state, 
 M is the total number of states in the state space ξ of the system, 
  is the action being considered, ia
isa
R  is the immediate reward obtained for performing action  in state s, 
(whose value is obtained from the reward matrix). 
ia
  A(s) is the set of all actions possible in state s, 
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)a,j,s(p i
ia
is the transition probability to go from state ‘s’ to state ‘j’ with 
action ‘ ’. 
Theoretically, this updating of the values and improvement of the policy 
continues forever, requiring infinite number of iterations to converge to the exact optimal 
values and to obtain the optimal policy. But, in reality, the updating of the values and 
improving the policy is stopped after a finite number of iterations when the values change 
by only a small amount. The policy obtained is the optimal policy. 
The average system reward by following the optimal policy obtained from the 
value iteration algorithm is 43.8790.  
5.3 Policy differences 
The difference between the value iteration technique and the proposed 
methodology is 1.21985, which is 1.22QALY’s or 445.25days.The percentage difference 
between the two techniques is 2.825%. Part of the policies obtained by the help of these 
two techniques is given in Table 3 showing some of the differences between them. These 
differences partly contribute to the difference in the average reward obtained using them. 
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Table 4. Differences in policies of value iteration and reinforcement learning 
State 
Position State 
Value 
Iteration 
Policy 
 
RL 
Policy 
384 (3, 0, 0, 3,0) 2 0 
572 (3,0,1,2,0) 2 0 
760 (4,0,0,1,0) 0 2 
762 (4,0,0,2,0) 0 2 
764 (4,0,0,3,0) 0 2 
766 (4,0,0,4,0) 0 2 
768 (4,0,0,5,0) 0 2 
770 (4,0,0,6,0) 0 2 
1520 (2,1,0,0,0) 2 3 
1523 (3,1,0,0,0) 0 3 
1526 (4,1,0,0,0) 0 2 
1531 (5,1,0,0,0) 0 1 
Note: All values are in generic units 
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CHAPTER 6 
CONCLUSIONS 
 
 
6.1 Concluding remarks 
Medical decision making problems are typically characterized by a large number 
of different patient health conditions and many available treatment choices. Predicting the 
effect of a single treatment choice on the patient’s health might not be difficult. But, 
predicting the effect of a chosen sequence of treatments, over the evolving health 
conditions of the patient with time, is perhaps impossible.  
Medical decision problems often involve such sequential treatment strategies 
taken over a period of time. The objective of such treatment strategies involves choosing 
the best treatment from the available choice, in every health state of the patient such that, 
a preferred benefit measure is optimized. There is no existing framework to help analyze 
such sequential medical decision problems to obtain an efficient solution. 
 This thesis develops an efficient solution methodology for obtaining treatment 
strategies in sequential medical decision problems. The methodology involves modeling 
of the problems as a Markov decision process, and obtaining a solution using a 
reinforcement learning approach. Modeling as a Markov decision process accounts for 
the sequential nature of the problem, and the reinforcement learning based approach 
helps in obtaining a computationally efficient solution. 
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A medical intervention problem, Hereditary Spherocytosis (HS), with five 
treatment choices has been identified as a test bed to apply the methodology. In 
particular, after the physician has diagnosed a patient suffering from HS, the physician 
depending on the health condition of the patient tries to decide on a strategy, out of the 
possible strategies available in that particular health state. The benefit measure chosen, 
here, is the QALYs of a patient and the objective of the physician is to maximize the 
quality of life of the patient, over the patient’s life. The solution obtained in terms of 
average total QALYs that can be obtained over a patient’s lifetime has been compared 
with the optimal solution obtained from the value iteration algorithm of dynamic 
programming.  
Experimental results using test data show that the proposed methodology can be 
effectively used to solve sequential medical decision problems with great reduction in 
computational effort when compared to the value iteration algorithms. Moreover, the 
optimal solution obtained by the proposed methodology was found to be quite close to 
that obtained using the value iteration algorithm of dynamic programming, hence giving 
a near optimal policy. The percentage difference, in the average total quality adjusted life 
years obtained per patient over the patients life, using the Value iteration technique and 
the reinforcement learning technique is found to be 2.825%. The difference being 
reasonable, it can be concluded that reinforcement learning is a viable alternative for the 
dynamic programming algorithms in obtaining a computationally effective solution. 
Moreover, reinforcement learning being a simulation-based methodology can be very 
useful in solving large-scale sequential decision problems in medicine.  
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6.2 Extensions to this work 
Some of the extensions to this work are as follows, 
T a reward scheme that accounts for cost of interventions and quantity of life along with 
the quality of life of the patient would make the model more realistic, 
T development of a methodology to abstract the outcomes of the various events, which 
can also be called as transition probabilities, from a medical database using data mining 
tools, 
T assumption that a patient lives for 100 years unless he encounters a surgical death or a 
death due to the side effects and complications due to certain treatment strategies can be 
relaxed to incorporate the natural death of the patient, which would be more realistic, 
T accommodation of factors like age and patient while assigning quality weights, 
T the issue that a patient being able to visit the physician whenever a problem arises, 
and the physician being able to take a treatment decision at any point of time, has not 
been incorporated in the present methodology. Therefore modeling the problems as a 
semi-Markov decision process to account for the changes occurring in the condition of a 
patient during a decision epoch, would considerably improve the model,  
T patient states, usually, in a medical scenario cannot be defined perfectly as they are 
not fully observable. Therefore, modeling as a partially observable Markov decision 
process (POMDP) would get the model much nearer to the real life scenario. 
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Appendix A: MARKOV DECISION PROCESS 
A Markov decision process is a stochastic process characterized by 5 elements, 
namely, decision epochs, states, actions, transition probabilities and rewards. Also, there 
may be an agent  (decision maker) that controls the path of the stochastic process. At 
certain points of time in the path, this agent intervenes and takes decisions, which affect 
the course of the future path. These points are called decision epochs and the decisions 
are called actions. At each decision epoch, the system occupies a decision making state. 
A vector that uniquely characterizes the system may describe this state. As a result of 
taking an action in a state, the decision maker receives a reward (which may be positive 
or negative) and the system goes to the next decision-making state with certain 
probability called the one-step transition probability. In a Markov process, the future state 
of the system depends only on the current state and the action chosen in the current state. 
A decision rule is a function for selecting an action in each state while a policy is a 
collection of such decision rules over the state space. A more formal definition of MDP is 
given next. 
Sequential decision making problems, that are completely characterized by 
Markov chains as their only underlying stochastic processes, are commonly referred to in 
the literature as MDPs. Let,  
{ }ξ∈∈= nn XNnXX ,:                                                 (A.1) 
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denote the underlying Markov chain of an MDP, where,  X n denotes the system state at 
the nth decision making epoch, ξ denotes the state space, and N denotes the set of  
integers. At any decision making epoch n, where, X n = i ∈  ξ, the action taken is An = a 
 A∈ i. Ai denotes the set of possible actions in state i and  UAi = A. Associated with any 
action a ∈  A is a transition probability matrix P(a) of the Markov chain X,  where P i j(a) 
represents the probability of moving from state i to j under action a. A reward function is 
defined as r: ξ ×A Æ R, where, R denotes the real line, and r (i,a) is the expected reward 
for taking action a in state i. It is assumed that the rewards are bounded, rewards and the 
transition probabilities are stationary, and the state space is finite. Also, for the sake of 
simplicity, markov chains that are aperiodic and unichain are only considered. 
The solution algorithms for MDPs, such as policy and value iteration, find the 
optimal stationary deterministic policy π * (which is a mapping π * : ξ Æ A) that 
maximizes the reward criterion. A stationary deterministic policy refers to a policy that is 
independent of time. The Bellman optimality equation, which lies at the heart of dynamic 
programming methods like policy and value iteration algorithms, is stated next after 
defining two important terms gain and bias. 
The gain for an MDP is defined as the average reward per period for a system in 
steady state under a given policy. When the system starts at any arbitrary state i and there  
after follows policy π , gain is given as 
r)A,X(rEN
1lim NN
N
1nN
ϕρ π =


 ∑=
=→∞ i
π ,                  (A.2) 
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where,  ϕ  denotes the limiting probability of the Markov chain X, and r is the reward 
vector {r(i,a) : i ∈ξ, a ∈  A}. The bias is defined as the expected total difference between 
the reward and average reward. Hence the bias in an MDP starting at state i and 
subsequently following policy π  is given as 
[ ] ∑ −= ∞=1n NNi )A,X(rE)i(h ρ πππ .      (A.3) 
 
A.1 Bellman optimality equation for average reward MDP’s 
Under considerations of average cost for an infinite time horizon for any finite 
unichain MDP, there exists a scalar ρ * and a value function R* satisfying the following 
system of equations for all i ∈  ξ, 


 ∑+−=
∈∈
)j(R)j,a,i(p)a,i(rmax)i(R *
j
*
Aia
*
ξ
ρ ,      (A.4) 
such that the greedy policy π * formed by selecting actions that maximize the right hand 
side of the above equation is average reward optimal, where r(i,a) is the expected 
immediate reward in state i, when an action a is taken, and p (i, a, j) is the probability of 
transition from state i to state j, under action a, in one state. 
 The average reward value iteration algorithm, which is one of many algorithms 
available for solving MDPs is given next. 
A.2 The average reward value iteration algorithm 
The value iteration algorithm is a method to iteratively obtain the optimal value 
function and the corresponding optimal policy using the bellman optimality equation. The  
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average reward version of the value iteration algorithm for MDPs (Puterman, 1994) [48], 
is presented next. 
Let Rm (i) be the total expected value of evolving through m stages starting at 
state i ∈  ξ, and ψ  is the space of bounded real valued functions on ξ. 
T Select R0 ∈  ψ , specify δ  > 0 and set m = 0 and a state k* ∈  ξ 
T For each i ∈  ξ, compute Rm+1 (i) by 



 +−= ∑
∈∈
+ )j(R)j,a,i(p)K(R)a,i(rmax)i(R m
j
*m
Aia
1m
ξ
.     (A.5) 
T If sp (Rm+1 – Rm) < δ , go to step 4. Otherwise increment m by 1 and return to 
step 2. sp denotes span, which for a vector ν  is defined as span(ν ) = max ν  (i) – 
min ν  (i). 
T For each i ∈  ξ, choose the action d δ (i) as 



 ∑+=
∈∈ ξδ j
m
Aia
)j(R)j,a,i(p)a,i(rmaxarg)i(d ,    (A.6) 
and stop. 
A value iteration sweep through the whole state space  simultaneously updates the 
values in every iteration. This creates a considerable computational challenge, especially, 
for problems with large state space. 
 Even under favorable conditions, convergence of the average reward value 
iteration algorithm is very slow since Vn diverges linearly in n, becomes numerically 
unstable. A relative value iteration algorithm avoids this difficulty, but does not enhance  
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the rate of convergence. An asynchronous version of the relative value iteration avoids 
the sweep through the whole state space by updating the value of one state at a time. Such 
algorithms still require the complete knowledge of the system’s probability structure and 
thus are difficult to implement for large systems. The computation of these quantities for 
problems with very large state spaces can become almost impossible. Hence, obtaining an 
optimal solution using these methods is often quite difficult.  
In recent years, an alternative approach, called Reinforcement Learning (RL) that 
is based on simulation-based stochastic approximation has become a topic of intense  
research interest. Convergent algorithms based on this method have been shown to obtain 
near-optimal policies for Markov decision problems with a considerable reduction in 
computational effort. Reinforcement Learning algorithms have two distinct advantages 
over DP algorithms. The first advantage is that they can handle problems with complex 
reward and stochastic structures since they use simulation as a modeling tool. Secondly, 
RL can integrate within its various function approximation methods (regression, neural 
networks etc.), which makes it possible to solve problems with large state spaces. 
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Reinforcement Learning (RL) is a way of teaching learning agents (decision 
makers) to predict the policy. This is accomplished by assigning rewards and 
punishments for their actions based on temporal feedback obtained during active 
interactions of learning agents with dynamic systems. Any learning model basically 
contains 4 elements, which are the environment, learning agents, and a set of actions for 
each agent and the environmental response (sensory input). Each learning agent selects 
an action and their actions collectively will lead the system along a unique path till the 
system encounters another decision making state. During this state transition, the agents 
gather sensory outputs from the environment, and from it, derives information about the 
new state and immediate reward. Using the information obtained during the state 
transition in conjunction with the algorithm, the agent updates its knowledge base and 
selects the next action. As this process repeats, the learning continues to improve its 
performance. A reinforcement-learning model is depicted in Figure 9. The learning agent 
provides the environment (system) with actions, and in return receives the sensory inputs 
that determine the next state and the reward or punishment resulting from its most recent 
action. On the nth step of interaction, based on the system state xn = i and the 
reinforcement values R(i) = {R(i,a) : a ∈  Ai} for the a available actions, the agent takes 
an action a, where R* (i) = maxaR(i,a). The system evolves stochastically in response to 
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the input state-action pair (i,a) and results in outputs concerning the next system state xn+1 
and the reward (or punishment) r (xn,xn+1) obtained during the transition. These system  
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Figure 9. A reinforcement learning model 
outputs serve as the sensory inputs for the agent. From these sensory data, the input 
function I helps the agent in perceiving the new system state.  
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Using the information about the new state (from I) and the sensory data about the reward 
(punishment), the reinforcement function R calculates the new action values R(i) for the 
previous state (xn = i). 
There are two different factors that determine the utility of an action. One is the 
immediate reward and other is the action value of the state to which the transition occurs 
as a result of that action. When a system visits a state, the decision maker chooses an 
action with highest (or lowest for minimization) action value (greedy policy). Initially, 
the action values for all state-action pairs are assigned arbitrary equal values (e.g., 
zeroes). When a system visits a state for the first time, a random action gets selected 
because all the action values are equal. As the system revisits the state, the learning agent 
selects the action based on the current action values, which are no longer equal. For 
ergodic processes, the states continue to be revisited and consequently the agent gets 
many opportunities to refine the action values and the corresponding decision making 
process. Sometimes, the learning agent chooses an action other than that suggested by the 
greedy policy. This is called exploration. As the good actions rewarded and bad actions 
punished over time, for every state, the action values of a smaller subset (one or more) of 
the actions tend to grow and others diminish. The learning phase ends when a clear trend 
appears with one or more actions in every state being dominant. These actions constitute 
the decision policy vector. 
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There are three different types of reinforcement learning models that have been 
studied most. In the finite horizon model, the agent optimizes the expected reward for a 
finite (h) number of steps,  
which is given by  


 ∑
=
h
0n
nrE ,             (B.1) 
where rn is the scalar reward received from the nth step of the horizon. Hence, the agent’s 
action on the first step is the h-step optimal action, on the second step h-1 step optimal 
action, and so on. The other two RL model types are infinite horizon models with average 
reward and discounted reward as their performance measures, which are given as 


 ∑
=∞→
h
0n
nh h
1Elim γ ,                         (B.2) 
and 


 ∑∞
=0n n
n rE γ ,              (B.3) 
where, γ  (0 < γ  < 1) is the discounting factor used per period. The concept of average 
reward is discussed briefly next. 
B.1 Average reward RL 
In most systems, the optimal total expected reward is finite either because of 
discounting or because of a reward-free termination state that the system eventually 
enters. In most situations, however, discounting is inappropriate and there is no natural  
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reward-free state. This makes it meaningful to optimize the average reward per stage 
starting from a state i, which is defined for any policy π  = (π 0, π 1, π 2,…..) by  


 == ∑−
=∞→
1N
0k
0N
)i|)j,a,i(r(E
N
1lim)i(R iπ ,      (B.4) 
assuming that the limit exists, where r (i, a, j) is the reward received by taking action a in 
state i and going to state j. 
B.2 Model based RL 
One of the biggest difficulties encountered in solving MDPs with complex 
probability structures is to set up the transition probability matrices (TPM). If the TPM is 
available through mathematical calculations, one can always use classical methods like 
value iteration or policy iteration. Model-based RL usually computes the functions, such 
as transition probabilities and rewards using simulation. As the simulation progresses, the 
learning agent gets an improving estimate of these functions, and uses them in solution 
algorithms (e.g., Sutton, 1992) [49]. But the curse of dimensionality remains a problem 
with model-based RL. The ongoing research by the RL community is directed toward 
solving the dimensionality problem. 
B.3 Model free RL 
The model-based RL algorithms estimate the transition probabilities using 
simulation. Hence, a strong disadvantage of DP (i.e., the need for computation of  
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transition probabilities) is not avoided. The algorithms that obviate this need are referred 
to as model-free algorithms. Model-free algorithms can infer R-values directly from 
sample paths generated by simulation. For problems with large state spaces, the R- values 
need to be represented by some standard function approximator, such as a feed forward 
neural network, or a nearest neighbor Kernel regression algorithm. 
 Model-free algorithms belong to a class of stochastic iterative algorithms, of 
which a usual updating scheme for action values can be described as follows. Suppose 
that when an action a is chosen in state i, it results in an immediate reward of rimm(i,a) and 
a system transition to state j. Then, the action value for the state-action pair (i,a) is 
updated as follows. 
[ ])a,i(R~)a,i(r)a,i(R)1()a,i(R immoldnew ++−= αα ,         (B.5) 
where, α  is the learning rate, and R~ (i,a) is an estimate of R (i,a) calculated from the 
feedback obtained during the system simulation. The exact form of R~ (i,a) depends on the  
algorithm chosen and also on the performance metric. Q-learning and R-learning 
(Kaelbling et al., 1996) [50], SMART (Das et al., 1999) [51], RELAXED-SMART 
(Gosavi, 1999) [46] are all examples of model-free RL. 
B.4 RL and DP 
The relationship between DP and RL, which has its foundation in the DP 
framework, is discussed here. RL uses an interactive style of learning to obtain the 
optimal actions through trial and error.  
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The algorithms that drive the learning agent use the so-called reinforcement 
values that are actually related to the value function in DP are given below. 
)a,i(Rmax)i(J a=               a ,i∀ )(iA∈ ,                      (B.6) 
where, J (i) is the value function for state i, R(i,a) is the reinforcement value of taking 
action a in state i, and A (i) is the set of actions available in state i. RL calculates the 
reinforcement values (action values) for each state-action pair iteratively (using the well 
known Bellman equation) whenever a state-action pair is visited by simulating the 
system. DP, on the other hand, iterates over the reinforcement values of each state-action 
pair using the Bellman equation and pre-calculated transition probability and reward 
values. Hence, the primary difference between RL and DP is that RL stochastically  
approximates the system evolution through its state-action pairs, and DP considers 
random but stationary system state-action evolution. 
B.5 RL and temporal difference methods 
Here, the concept of temporal differences with reference to RL is discussed. The 
concept of temporal differences (TD)  is central to the development of all algorithms in 
RL whether model-based or model-free. In this section, the following notational  
convention is used. For any given trajectory i0, i1,….., iN, with iN = 0, and policy π = (π 0, 
π 1,….), let r (i, π i, j) be the reward obtained by going from state i to state j under action 
π i. Also, let i k = 0, for k > N, and also r (i k, π k, i k+1) = 0 for k >= N. It is assumed 
further that for any value function vector Rπ (.), Rπ (0) is zero.  
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For a trajectory (i0, i1,.….., iN) that is generated, the reward estimates (value function) 
Rπ (i k) , k=0,….,N-1, can be updated as follows, 
)).i(R)i,,i(r(.......)i,,i(r(
)i,,i(r)(i()i(R)i(R
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+       (B.7) 
Note that the above equation is actually the first step of policy evaluation in policy 
iteration methods. The update formula can be rewritten, for R (i N) = 0, as follows, 
))i(R)i(R)i,,i(r())......i(R
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The above equation is equivalent to Sutton’s TD (1) update and can be expressed as 
)d...dd()i(R)i(R 1N1kkkk −+ ++++← γππ ,       (B.9) 
where, d k denotes the kth temporal difference and is given by  
)i(R)i(R)i,,i(rd k1k1kkkk πππ −+= ++ .         (B.10) 
 
The temporal difference d k represents the difference between an estimate of the 
value function (r (i k, π k, i k+1) + R π (i k+1)) based on the simulated outcome of the 
current stage, and the current estimate Rπ (i k). Thus the temporal difference provides an 
indication as to whether the current estimates R(i) should be raised or lowered.  
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